close

Enter

Log in using OpenID

here - AGW

embedDownload
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
Posters are placed in numerical order
in the following categories:
в—Џв—Џ
BASIC SCIENCE LIVER
в—Џв—Џ
LUMINAL CLINICAL
в—Џв—Џ
BASIC SCIENCE LUMINAL
в—Џв—Џ
MOTILITY/NEUROGASTROENTEROLOGY
в—Џв—Џ
ENDOSCOPY – LOWER
в—Џв—Џ
NUTRITION
в—Џв—Џ
ENDOSCOPY – UPPER
в—Џв—Џ
PAEDIATRICS
в—Џв—Џ
HEPATOLOGY – CLINICAL
в—Џв—Џ
VIRAL HEPATITIS
в—Џв—Џ
IBD – CLINICAL
BASIC SCIENCE LIVER
18
THE PROTEASE FIBROBLAST ACTIVATION PROTEIN (FAP) IN LIVER DISEASE
Mark Gorrell, Kathryn Williams, Ana Julia Viera de Ribeiro, Sumaiya Chowdhury, Elizabeth Hamson, Oliver Schilling,
Emilia Prakoso, Nicholas Shackel, Susan McLennan, William Bachovchin, Fiona Keane, Geoffrey McCaughan, Amany
Zekry, Stephen Twigg
46
DELETION OF THE CYTOPLASMIC DOMAIN OF TISSUE FACTOR AMELIORATES LIVER FIBROSIS AND DECREASES TGF Β
EXPRESSION IN A MURINE MODEL OF CIRRHOSIS
Virginia Knight, Jorge Tchongue, Dinushka Lourensz, Alison Liu, Peter Tipping, William Sievert
56
THE POTENTIAL ROLE OF LIPOPOLYSACCHARIDES IN THE DEVELOPMENT OF BILIARY INJURY IN AN ANIMAL PARTIAL LIVER
ISCHAEMIA MODEL
Janske Reiling, KR Bridle, N Santrampurwala, LJ Britton, DHG Crawford, CHC Dejong, J Fawcett
66
ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) GENE THERAPY USING A HIGH EFFICIENCY AND LIVER-SPECIFIC ADENOASSOCIATED VIRAL VECTOR ATTENUATES EXPERIMENTAL LIVER FIBROSIS IN MICE
Kai Yan Mak, Ruth Chin, Joe Torresi, Sharon Cunningham, Ian Alexander, Peter Angus, Chandana Herath
83
JAGGED2 IS A MASTER REGULATOR OF LIVER CANCER STEM CELL
Guang Wu, Guang Wu, George Wilson, Jacob George, Liang Qiao
84
TLR9 MAY BE A DOUBLE EDGED SWORD IN THE LIVER: IS IT PATHOGENIC OR PROTECTIVE IN NASH?
Auvro Mridha, Fahrettin Haczeyni, Matthew Yeh, Geoff Haigh, Vanessa Barn, Hussam Ajamieh, Jeffrey Hamdorf, Leon
Adams, Narci Teoh Geoffrey Farrell
87
THE ROLE OF RECEPTOR-MEDIATED ENDOCYTOSIS OF H-FERRITIN-INDUCED PROINFLAMMATORY SIGNALLING IN HEPATIC
STELLATE CELLS
Grant Ramm, Manuel Fernandez-Rojo, Anita Burgess, Amber Glanfield, Diem Hoang-Le, Nathan Subramaniam, Grant
Ramm
168
SPACIOTEMPORAL CHARACTERIZATION OF THE CELLULAR AND MOLECULAR CONTRIBUTORS TO CHRONIC HEPATIC
FIBROSIS IN A HEPATOTOXIN-INDUCED MOUSE MODEL
Michelle Melino, Victoria Gadd, Michelle Martinez, Katie Lineburg, Katharine Irvine, Andrew Clouston, Elizabeth Powell,
Kelli MacDonald
13
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
224
EXERCISE SLOWS GROWTH OF DYSPLASTIC HEPATOCYTES BY IMPROVING INSULIN SENSITIVITY AND ENHANCING DNA
DAMAGE SURVEILLANCE PATHWAYS IN MICE GENETICALLY PREDISPOSED TO OBESITY AND DIABETES
Evi Arfianti, Vanessa Barn, W Geoffrey Haigh, George N Ioannou, Narci Teoh, Geoff Farrell
242
THE ROLE OF ADIPONECTIN AND T-CADHERIN INTERACTIONS IN LIVER FIBROSIS
Badr ALzahrani
247
WHAT CAUSES KUPFFER CELL ACTIVATION IN NAFLD? HMGB1, TLR4, CRYSTALS AND NLRP3 INFLAMMASOME LINK FREE
CHOLESTEROL TO INHIBITABLE PRO-INFLAMMATORY PATHWAYS IN NASH
Lay T Gan, Derrick M Van Rooyen, Matthew Cooper, Avril Robertson, Seth Masters, Narci Teoh, Geoff Farrell
250
MANIPULATION OF DIETARY ADVANCED GLYCATION END-PRODUCT CONTENT INFLUENCES THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Christopher Leung, CB Herath, J Zhiyuan, T Leong, JM Forbes, PW Angus
271
INVESTIGATION OF MICE DEFICIENT IN MATRIPTASE-2, HFE AND TRANSFERRIN RECEPTOR 2 REVEALS A NOVEL NONHEPATIC ROLE FOR TFR2 IN ERYTHROPOIESIS
Daniel Wallace, Eriza Secondes, Gautam Rishi, Lesa Ostini, Cameron McDonald, Steven Lane, John Hooper, Carlos
Lopez-Otin, V. Nathan Subramaniam
292
SERUM-FREE HEPATOCYTIC TRANSDIFFERENTIATION OF PANCREATIC PROGENITOR CELLS FACILITATED BY
EXTRACELLULAR MATRIX PROTEINS
Nina Tirnitz-Parker, Francis Gratte, John Olynyk, George Yeoh, David Tosh, Deirdre Coombe
294
A NOVEL FLEXIBLE ENDOSCOPY-CAPABLE OXYGEN PROBE CAN DETECT PANCREATIC ISCHEMIA IN A RAT MODEL OF
CHRONIC PANCREATITIS
Payal Saxena, Sandeep Akshintala, Brian Simons, Kathleen Gabrielson, Vivek Kumbhari, Pankaj Pasricha, Vikesh Singh,
Mouen Khashab, Anthony Kalloo
299
HEPATIC MICRORNA EXPRESSION IS ALTERED IN A MURINE MODEL OF IRON AND FAT CO-MEDIATED LIVER INJURY
Cameron McDonald, Yin Yuan, Nishreen Santrampurwala, Darrel Crawford, Nathan Subramaniam
303
HEAT SHOCK PROTEIN 47 IS A POTENTIAL THERAPEUTIC TARGET FOR THE DEPLETION OF CANCER-PROMOTING STROMAL
CELLS IN PANCREATIC CANCER
Phoebe Phillips, Janet Youkhana, Joshua McCarroll, George Sharbeen, Mert Erkan, Jie Liu, David Goldstein
BASIC SCIENCE LUMINAL
14
17.
APPLICABILITY OF NEXT GENERATION SEQUENCING TECHNOLOGY IN MICROSATELLITE INSTABILITY TESTING
Chun Gan, Clare Love, Victoria Beshay, Finlay Macrae, Stephen Fox, Paul Waring, Graham Taylor
20.
POLYMORPHISMS IN C. CONCISUS ZOT AFFECT THE CLEAVAGE OF ZOT PROTEINS BY BACTERIAL PROTEASES
Vikneswari Mahendran, Hoyul Lee, Fang Liu, Sheryln Sabrina, Rena Ma, Stephen M Riordan, Michael C Grimm, Li Zhang
21.
THE EFFECTS OF GASTROINTESTINAL ENVIRONMENTAL FACTORS ON CAMPYLOBACTER CONCISUS GROWTH
Rena Ma, Nicholas Sapwell, Hoyul Lee, Vikneswari Mahendran, Rupert Leong, Michael Grimm, Stephen Riordan, Li
Zhang
22.
DETECTION OF THE ZONULA OCCLUDENS TOXIN EXPRESSED IN CAMPYLOBACTER CONCISUS STRAINS
Hoyul Lee, Fang Liu, Vikneswari Mahendran, Li Zhang
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
34.
MODELLING THE EARLY DYSPLASTIC CHANGES IN COLITIS-ASSOCIATED COLORECTAL CANCER USING SPONTANEOUS
MURINE COLITIS
Sarron Randall-Demllo, Raj Eri, Anthony Cook, Dane Hayes, Kevin Spring
35.
AQUEOUS RHUBARB EXTRACT IMPROVES ILEAL MUCOSAL INTEGRITY AND REDUCES ACUTE INFLAMMATION IN A RAT
MODEL OF 5-FLUOROURACIL-INDUCED INTESTINAL MUCOSITIS
Juliana Bajic, Georgina Eden, Lorrinne Lampton, Ker Cheah, Kerry Lymn, Andrea Yool, Gordon Howarth
36.
OSTRICH OIL FAILED TO IMPROVE INTESTINAL BARRIER FUNCTION FOLLOWING 5-FLUOROURACIL-INDUCED MUCOSITIS IN
RATS
Juliana Bajic, Ker Cheah
37.
ESCHERICHIA COLI NISSLE 1917 DERIVED FACTORS REDUCE CELL DEATH, LATE APOPTOSIS AND INCREASE
TRANSEPITHELIAL ELECTRICAL RESISTANCE IN A MODEL OF 5-FLUOROURACIL-INDUCED INTESTINAL EPITHELIAL CELL
DAMAGE
Juliana Bajic, Hanru Wang, Susan Bastian, Ker Cheah, Andrew Lawrence, Suzanne Mashtoub, Gordon Howarth
38.
FACTORS DERIVED FROM ESCHERICHIA COLI NISSLE 1917, GROWN IN DIFFERENT GROWTH MEDIA, ENHANCE CELL DEATH
IN A MODEL OF 5-FLUOROURACIL-INDUCED CACO-2 INTESTINAL EPITHELIAL CELL DAMAGE
Juliana Bajic, Hanru Wang, Susan Bastian, Andrew Lawrence, Suzanne Mashtoub, Gordon Howarth
39.
EMU OIL IN COMBINATION WITH LYPRINOLв„ў REDUCES SMALL INTESTINAL DAMAGE ASSOCIATED WITH CHEMOTHERAPYINDUCED MUCOSITIS IN RATS
Juliana Bajic, Lorrinne Lampton, Georgina Eden, Ker Cheah, Kerry Lymn, Suzanne Mashtoub, Gordon Howarth
49.
APPEARANCE OF TUMOR-DERIVED METHYLATED DNA IN PLASMA CORRELATES WITH COLORECTAL TUMOUR INVASION
Dileep Mangira, Ronan Baker, Erin Symands, Stephen Cole, Libby Bambacas, Susanne Pederson, David Murray,
Lawrence LaPointe, Greame Young
79.
INTEGRATED GENOME WIDE DNA METHYLATION AND GENE EXPRESSION ANALYSIS IDENTIFIES SUBGROUPS OF
COLORECTAL CANCER WITH DISTINCT MOLECULAR AND CLINICAL FEATURES
Troy Dumenil
92.
ISOCITRATE DEHYDROGENASE 1 R132C MUTATION OCCURS EXCLUSIVELY IN MICROSATELLITE STABLE COLORECTAL
CANCERS WITH THE CPG ISLAND METHYLATOR PHENOTYPE
Vicki Whitehall, Troy Dumenil, Diane McKeone, Catherine Bond, Mark Bettington, Ron Buttenshaw, Lisa Bowdler, Grant
Montgomery, Leesa Wockner, Barbara Leggett
94.
RNF43 IS A FREQUENT MUTATIONAL TARGET IN THE SERRATED PATHWAY OF COLORECTAL CARCINOGENESIS
Vicki Whitehall, Diane McKeone, Jonathan Ellis, Catherine Bond, Mark Bettington, Sally Pearson, Barbara Leggett
128.
TUBULOVILLOUS ADENOMA WITH PROMINENT ARCHITECTURAL SERRATION – A CLINICOPATHOLOGICAL AND MOLECULAR
APPRAISAL OF A NEW SUBTYPE OF COLORECTAL POLYP
Neal Walker, Ian Brown, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane McKeone, Barbara Leggett, Vicki
Whitehall
129.
CHANGING INCIDENCE OF BRAF AND KRAS MUTATIONS IN COLORECTAL CARCINOMA
Mark Bettington, Ian Brown, Neal Walker, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane McKeone,
Barbara Leggett, Vicki Whitehall
130.
WNT SIGNALING IN AN UNSELECTED SERIES OF COLORECTAL CARCINOMAS
Mark Bettington, Catherine Bond, Ian Brown, Neal Walker, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane
McKeone, Barbara Leggett, Vicki Whitehall
15
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
16
165.
DIFFERENTIAL EFFECTS BETWEEN PROTON PUMP INHIBITORS ON CLOPIDOGREL-MEDIATED ANTI-PLATELET INHIBITION
Paul Spizzo, Samantha Cole
174.
METHYLATION AND EXPRESSION OF THE TUMOUR SUPPRESSOR, PRDM5, IN COLORECTAL CANCER SUBGROUPS
Catherine Bond
181.
HYPOXIA INDUCIBLE FACTOR 1α (HIF-1α) REGULATES ANTI-INFLAMMATORY LYMPHOID RESPONSES DURING
COLITIS
Ellen Marks, Gavin Nolan, Sean Mateer, Kyra Minahan, Bridie Goggins, Jocelle Cardona, Simon Keely
184.
OBESE VISCERAL ADIPOSE TISSUE EXHIBITS ALTERED T CELL TRAFFICKING PATTERNS AND CONFERS A UNIQUE
PHENOTYPE TO TISSUE- RESIDENT T CELLS
Sukanya Raghuraman, Andrew R Lloyd, Amany Zekry
187.
IMMUNE CELL MIS-HOMING DRIVES SECONDARY ORGAN INFLAMMATION IN INFLAMMATORY BOWEL DISEASE; A FOCUS ON
THE RESPIRATORY SYSTEM
Sean Mateer, Steven Maltby, Ellen Marks, Bridie Goggins, Jay Horvat, Philip Hansbro, Simon Keely
219.
RETINOIC ACID IS REQUIRED FOR THE GENERATION OF PROTECTIVE APPENDICEAL REGULATORY T CELLS
Annie Luo, Andrew Lim, Hye-Jee Jung, Phillips Phoebe, Michael Grimm
225.
RECREATING THE INTESTINAL MACROPHAGE IN VITRO: A POTENTIAL ROLE FOR STROMAL FACTORS
Greta Lee, Michael Grimm
227.
THE IMPACT OF APPENDICITIS ON RORGAMMAT+ INNATE LYMPHOID CELLS
Louis Yeung, Michael Grimm
234.
HYPOXIA INDUCIBLE FACTOR (HIF)-1 ACCELERATES EPITHELIAL WOUND HEALING THROUGH INTEGRIN REGULATION
Bridie Goggins, Kyra Minahan, Ellen Marks, Sean Mateer, Jocelle Cardona, Darryl Knight, Jay Horvat, Simon Keely
236.
ORAL NUCLEOTIDES ONLY MINIMALLY IMPROVE 5-FLUOROURACIL-INDUCED MUCOSITIS IN RATS
Juliana Bajic, Suzanne Mashtoub, B Feo, Alexander Whittaker, Kerry Lymn, D Marinez-Puig, Gordon Howarth
237.
THE ROLE OF ANTIBIOTICS IN THE DEVELOPMENT OF FOOD ALLERGY
Jocelle Cardona, Ellen Marks, Bridie Goggins, Sean Mateer, Kyra Minahan, Jay Horvat, Simon Keely
239.
SAFETY OF EMU OIL FOR INTESTINAL APPLICATIONS
Juliana Bajic, Suzanne Mashtoub, Ker Cheah, Gordon Howarth
241.
EMU OIL SOURCE DOES NOT SIGNIFICANTLY ALTER THERAPEUTIC EFFICACY, WHILST OSTRICH OIL HAS NO BENEFICIAL
EFFECT, IN A RAT MODEL OF CHEMOTHERAPY-INDUCED MUCOSITIS
Juliana Bajic, Suzanne Mashtoub, Ker Cheah, NLC Lansdown, Gordon Howarth
243.
ACUTE TUMOUR NECROSIS FACTOR ADMINISTRATION INDUCES TRANSIENT EPITHELIAL CELL SHEDDING, MUCOSAL LEAK
AND NEUTROPHIL RECRUITMENT TO THE GUT IN A MOUSE MODEL
Jeff Chang, Rupert Leong, Mehreen Arshi, Tri Phan, Antony Kelleher, Mark Danta
261.
THE MAJOR PATHWAY BY WHICH POLYMERIC FORMULA REDUCES INTESTINAL INFLAMMATION IN CROHN’S DISEASE
PATIENTS - A MICROARRAY-BASED ANALYSIS
Steven Leach, Lily Nahidi, J Wei, Daniel Lemberg, Andrew Day
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
288.
ASSOCIATION OF SEROLOGICAL EPITHELIAL COMPONENT PROTEINS WITH COMPLICATED CROHN’S DISEASE BY DISCOVERY
AND VERIFICATION PHASE PROTEOMICS
Yunki Yau, Rupert WL. Leong, Aviv Puddipeddi, Varan Perananthan, Diane Redmond, Jeff Chang, Valerie C. Wasinger
317.
INSTITUTING MODERN MANAGEMENT OF EOSINOPHILIC ESOPHAGITIS IN AUSTRALIA; LESSONS FROM OUR FIRST 65
PATIENTS USING A STRUCTURED CLINICAL ALGORITHM
Hamish Philpott, Sanjay Nandurkar, Peter Gibson
340.
THE INSIGHT VARIANT INTERPRETATION COMMITTEE – STANDARDISED CLASSIFICATION OF MISMATCH REPAIR GENE
VARIANTS IN LYNCH SYNDROME
Finlay Macrae, Bryony Thompson, John-Paul Plazzer, Amanda Spurdle
ENDOSCOPY – LOWER
11.
OPTIMISATION OF ENDOSCOPIC FOLLOW-UP WAITING LISTS IN A NEW ZEALAND DISTRICT HEALTH BOARD
Neeraj Bhala, Helen Myint, Joan Lewis, Carey Virtue, Adam Simpson, Rees Cameron
24.
EFFECT OF SPLIT-DOSE BOWEL PREPARATION ON POLYP DETECTION RATE AND ADENOMA DETECTION RATE IN A
REGIONAL SETTING IN VICTORIA
Neel Heerasing, Barry Morphett
41.
ENDOSCOPIC MANAGEMENT OF LARGE SESSILE SERRATED ADENOMAS IS SAFE AND EFFECTIVE: OUTCOMES FROM A
MULTICENTRE PROSPECTIVE COHORT STUDY
Maria Pellise, Nicholas Burgess, Nicholas Tutticci, Luke F Hourrigan, Simon A Zanatti, Gregor J Brown, Rajvinder Singh,
Stephen J Williams, Spiro C Raftopoulos, Alan Moss, Donald G Ormonde, Heok P’Neg, Duncan Mc Leod, Michael J Bourke
43.
PROSPECTIVE CHARACTERISATION OF THE MUCOSAL DEFECT AFTER COLD SNARE POLYPECTOMY
Nicholas Tutticci, Nicholas Burgess, Maria Pellise, Duncan Mcleod, Michael J Bourke
48.
THE ROLE OF A UNIVERSAL OR SELECTIVE ENDOSCOPIC SUBMUCOSAL DISSECTION STRATEGY FOR LARGE SESSILE AND
LATERALLY SPREADING COLORECTAL TUMOURS IN A WESTERN TERTIARY REFERRAL CENTRE
Farzan Bahin, Khalid Rasouli, Duncan McLeod, Hema Mahajan, Stephen Williams, Eric Lee, Rebecca Sonson, Michael
Bourke
104.
RATES OF COLONOSCOPY IN THE 3 YEARS PRIOR TO A DIAGNOSIS OF COLORECTAL CANCER IN WESTERN AUSTRALIA:
ASSESSMENT OF RISK FACTORS FOR MISSED AND INTERVAL CANCERS. PRELIMINARY RESULTS FROM A POPULATIONBASED STUDY
Salama Muna, Harma Claire
111.
THE ADDITION OF HISTOLOGY TO CONTINUOUS AUDIT HAS SIGNIFICANTLY INCREASED ADENOMA DETECTION RATE IN A
PRIVATE ENDOSCOPY UNIT
Alan Fraser, Greg Gamble, Toby Rose
113.
THE FINANCIAL BURDEN OF POOR BOWEL PREPARATION IN COLORECTAL CANCER SCREENING IN A TERTIARY HOSPITAL
OUT-PATIENT DEPARTMENT
Kendall Williams, Jenny McDonald, Thomas Lee, Ria Kanazaki
132.
TERMINAL ILEAL INFLAMMATION IS ONLY SIGNIFICANT IN AN APPROPRIATE CLINICAL CONTEXT
Shara Ket, Gillian Skardoon, Sheetal Deshpande, Haque Tasneem, Stephen Pianko
17
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
18
134.
IMPROVED STRATIFICATION OF SUBMUCOSAL INVASIVE CANCER RISK IN ADVANCED MUCOSAL NEOPLASIA OF THE
COLON BY INTEGRATING GROSS MORPHOLOGY, SURFACE CHARACTERISTICS AND LOCATION: RESULTS FROM A LARGE
MULTICENTER COHORT
Nicholas G Burgess, Luke F Hourigan, Simon A Zanati, Gregor J Brown, Rajvinder Singh, Stephen J Williams, Spiro C
Raftopoulos, Alan Moss, Donald Ormonde, Michael J Bourke
137.
THE HISTOPATHOLOGICAL CORRELATES OF TWO ELECTROSURGICAL RESECTION MODALITIES IN AN IN-VIVO PORCINE
MODEL OF ENDOSCOPIC MUCOSAL RESECTION
Nicholas G Burgess, Farzan F Bahin, Maria Pellise, Rebecca Sonson, Rafael Perez-Dye, Shahrir Kabir, Vishnu
Subramanian, Hema Mahajan, Duncan J McLeod, Michael J Bourke
162.
EXTENDED WIDE FIELD ENDOSCOPIC MUCOSAL RESECTION IS NOT EFFECTIVE FOR REDUCING THE RISK OF RECURRENCE
AFTER WF-EMR OF ADVANCED COLONIC MUCOSAL NEOPLASIA
Maria Pellise, Nicholas G Burgess, Farzan F Bahin, Rebecca Sanson, Alsthensiel Golo, Stephen J Williams, Eric Lee,
Hema Mahajan, Duncan J McLeod, Michael J Bourke
171.
SALVAGE COLONOSCOPY USING COMBINED DISTAL CAP ATTACHMENT AND WATER INSUFFLATION IN PATIENTS WITH
PREVIOUS FAILED OR INCOMPLETE COLONOSCOPY: A CASE SERIES
Sze Pheh Yeap, William Tam
175.
SERVICE AND QUALITY IMPROVEMENT: ADVANCED HIGH DEFINITION ENDOSCOPY IMPROVES POLYP DETECTION RATES – AN
UNFAIR ADVANTAGE? – THE PRINCE CHARLES (TPCH) EXPERIENCE
Ben Law, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, Mark Appleyard, John Croese, Ruth
Hodgson, Tony Rahman
176.
INTRODUCTION OF COLON CAPSULE ENDOSCOPY IN AUSTRALIA
Finlay Macrae, Francesco Amico, Emma McLaughlin, Gabriel Segal
177.
SERVICE AND QUALITY IMPROVEMENT: SPLIT BOWEL PREP IMPROVES POLYP DETECTION RATES AND OTHER QUALITY
INDICATORS FOR COLONOSCOPY COMPARED TO STANDARD BOWEL PREPARATION – THE PRINCE CHARLES EXPERIENCE
Ben Law, Ha Nguyen, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, Mark Appleyard, John Croese, Ruth
Hodgson, Tony Rahman
186.
A SYSTEMATIC REVIEW OF THE PERFORMANCE AND COST-EFFICIENCY OF NURSE AND NON-PHYSICIAN ENDOSCOPISTS
Gerald Holtmann, Maximilian Stephens, Luke Hourigan, Mark Appleyard, George Ostapowicz, Mark Schoeman, Paul
Desmond, Jane Andrews, Michael Bourke, David Hewitt, David Margolin
193.
CONFOCAL LASER ENDOMICROSCOPY IN THE ASSESSMENT OF MUCOSAL EPITHELIAL BARRIER DEFECTS IN
INFLAMMATORY BOWEL DISEASES: INTER-, INTRA-OBSERVER AGREEMENT, LEARNING CURVE AND ACCURACY
Matthew Ip, Jeff Chang, Michael Yang, Brendon Wong, Tri Phan, Lisa Lin, Theresa Power, Rupert Leong
206.
A PROSPECTIVE DUAL CENTRE EVALUATION OF NARROW BAND IMAGING (NBI) WITH A FIXED ZOOM FUNCTION IN REAL TIME
PREDICTION OF POLYP HISTOLOGY. CAN WE RESECT AND DISCARD?
Niketh Kuruvilla, Ramesh Paramsothy, Gill Raghubinder, Matthew Remedios, Warwick Selby, Arthur Kaffes
208.
HIGH BMI: A RISK FACTOR FOR SIGNIFICANT COLONIC POLYPS
Mohammed Alansari, C. Schepisi
213.
QUALITY IN COLONOSCOPY: ADENOMA DETECTION RATE AUDIT IN AN AUSTRALIAN TERTIARY HOSPITAL
Yong C Jonathan TAN, Richard La Nauze, Robyn Secomb, Catherine Bunn, Peter Gibson, Gregor J Brown
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
215.
WIDE FIELD ENDOSCOPIC MUCOSAL RESECTION (WF-EMR) COMPARED TO SURGERY FOR LARGE SESSILE AND FLAT
COLONIC POLYPS: ECONOMIC ANALYSIS
Mahesh Jayanna, Nicholas Burgess, Rajvinder Singh, Luke Hourigan, Gregor Brown, Simon Zanati, Alan Moss, James
Lim, Rebecca Sonson, Stephen Williams, Michael Bourke
226.
ORAL REHYDRATION SOLUTION ORANGE VS BLACKCURRANT IN ADDITION TO STANDARD BOWEL PREPARATION FOR
COLONOSCOPY: A PILOT STUDY
Yong C Jonathan TAN, Richard La Nauze, Robyn Secomb, Catherine Bunn, Peter Gibson, Gregor J Brown
228.
FACTORS INFLUENCING SESSILE SERRATED ADENOMA (SSA) DETECTION RATES AT A MULTI-CENTRE METROPOLITAN
AUSTRALIAN HEALTH SERVICE
Jeremy Dwyer, Alan Moss
229.
CLINICAL SIGNIFICANCE OF SPORADIC LARGE SESSILE SERRATED ADENOMAS
Mahesh Jayanna, Maria Pellise, Kavinderjit Nanda, Nicholas Burgess, Rebecca Sonson, Duncan McLeod, Hema Mahajan,
Michael Bourke
233.
SESSILE SERRATED ADENOMA AND OVERALL POLYP DETECTION RATES BETWEEN PENTAX AND OLYMPUS
COLONOSCOPES IN A REGIONAL AUSTRALIAN HOSPITAL
Seema Shah, David Whitaker
259.
THE HISTOPATHOLOGIC EFFECTS OF ARGON PLASMA COAGULATION COMPARED WITH SNARE TIP SOFT COAGULATION IN
AN IN-VIVO PORCINE MODEL OF ENDOSCOPIC MUCOSAL RESECTION
Nicholas G Burgess, Farzan F Bahin, Maria Pellise, Sonson Rebecca, Rafael Perez-Dye, Shahrir Kabir, Vishnu
Subramanian, Hema Mahajan, Duncan J McLeod, Michael J Bourke
284.
ULCERATIVE COLITIS ENDOSCOPIC INDEX OF SEVERITY (UCEIS) HAS A SUPERIOR INTEROBSERVER AGREEMENT THAN THE
MAYO ENDOSCOPIC SUBSCORE IN THE EVALUATION OF ULCERATIVE COLITIS ACTIVITY
Liam Beiglari, Jeff Chang, Crispin Corte, Rupert Leong
289.
ADENOMA DETECTION RATE AT A TERTIARY CENTRE
Darren Wong, Poornima Varma, Peter Prichard
290.
SESSILE SERRATED ADENOMA PREVALENCE IN COMMUNITY GASTROENTEROLOGY PRACTICE
Georgia Hume, John Gibbons, Anthony Watt, John Pauli, Jillian Rosenstengel, Kate Cayzer, Paul Clark, Nicholas Tutticci
296.
A NATIONAL SURVEY OF AUSTRALIAN ENDOSCOPISTS’ ATTITUDES TOWARDS NURSE ENDOSCOPY
David Hewett, Ammar Kheir, Simone Mackrill, Lori Leach, Bernadette Watson
335.
SIGNIFICANCE OF SMALL BOWEL LIPID DEPOSITS SEEN ON CAPSULE ENDOSCOPY
Mian Li ooi, John Wettenhall, Kathryn Ogden
338.
LONG-TERM OUTCOMES OF PALLIATIVE THERAPY FOR OBSTRUCTION CAUSED BY INCURABLE STAGE IV COLORECTAL
CANCER IN PATIENTS WITH GOOD PERFORMANCE STATUS : ENDOSCOPIC STENT VERSUS SURGERY
Ahn Hyo Jun, Kim Sang Woo, Moon Sung Jin, Lim Chul-Hyun, Kim Jin Su, Cho Yu Kyung, Park Jae Myung, Lee In Seok,
Choi Myung-Gyu
19
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
ENDOSCOPY – UPPER
20
1.
ANTIPLATELET AND ANTICOAGULANT AGENT USE AT TIME OF GASTROINTESTINAL BLEEDING DOES NOT AFFECT CLINICAL
OUTCOMES
Ray Boyapati, Marcus Robertson, Avik Majumdar, William Chung, Rima Turbah, Rhys Vaughan, Steven Lontos
23.
FIRST REPORTED GASTRIC EXPLOSION INDUCED BY ARGON PLASMA COAGULATION (APC): A DEVASTATING COMPLICATION
PREVENTABLE BY A SIMPLE CHANGE IN ENDOSCOPIC PRACTICE
John Freiman, Toni Hampe
26.
PREVALENCE OF EOSINOPHILIC OESOPHAGITIS IN ADULTS PRESENTING WITH OESOPHAGEAL FOOD BOLUS OBSTRUCTION
Neel Heerasing, Shok Yin Lee, Damian Dowling, Sina Alexander
27.
PROSPECTIVE EVALUATION OF SIMPLIFIED ALGORITHM FOR EUS-GUIDED INTRA-HEPATIC BILIARY ACCESS AND
ANTEROGRADE INTERVENTIONS FOR FAILED ERCP
Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton
28.
ENDOSCOPIC ULTRASOUND-GUIDED COELIAC PLEXUS NEUROLYSIS: 3 YEAR EXPERIENCE
Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton
29.
ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL DRAINAGE OF PERI-PANCREATIC FLUID COLLECTIONS IS HIGHLY
EFFECTIVE AS PRIMARY ENDOSCOPIC THERAPY
Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton
44.
ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA): EXPERIENCE OF A REGIONAL CENTRE IN
AUSTRALIA
Chuang Ming-yu, Pei Yi Ong, Scott Fanning
53.
CAP-ASSISTED LIGATION ENDOSCOPIC MUCOSAL RESECTION (EMR) OF LOWER OESOPHAGEAL LESION: TISSUE
ACQUISITION OR CURATIVE TREATMENT
Frank Weilert, James Brooker, Graeme Dickson
69.
BLOOD TRANSFUSION IS ASSOCIATED WITH INCREASED MORTALITY RATE IN UPPER GASTROINTESTINAL BLEEDING
Kavitha Subramaniam, Katrina Spilsbury, Oyekoya T Ayonrinde, Faye Latchmiah, Aqif Mukhtar, James Semmens, John
K Olynyk
71.
SAFETY AND EFFICACY OF ENDOSCOPIC MANAGEMENT OF BARIATRIC SURGICAL COMPLICATIONS: A CASE SERIES
Sze Pheh Yeap, Leong Paul, Aiden Tieu, Singh Rajvinder, Biju George, Nind Garry, William Tam
93.
LEARNING CURVE FOR OPTICAL BIOPSY USING NARROW BAND IMAGING - CAN REAL-TIME TRAINING IMPROVE ACCURACY?
Sneha John, Jiyoung Lee, Lea Wiggins
117.
THE CURRENT PRACTICE OF ERCP IN AUSTRALIA: 2014 SURVEY
Alvin Ting, Daniel Croagh, Michael Swan, David Devonshire, Sina Alexander
123.
ERCP DURATION AND ITS RELATIONSHIP TO INDICATIONS AND COMPLICATIONS
Mohit Shetti, Andrew Thomson, Teresa Neeman
143.
RISK STRATIFICATION IN ACUTE UPPER GASTROINTESTINAL BLEEDING: AIMS65 IS SUPERIOR TO GLASGOW-BLATCHFORD
AND ROCKALL SCORING SYSTEMS IN PREDICTING INPATIENT MORTALITY
Avik Majumdar, Ray Boyapati, William Chung, Ryma Terbah, Tom Worland, James Wei, Steve Lontos, Rhys Vaughan,
Marcus Robertson
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
172.
CONFOCAL LASER ENDOMICROSCOPY IS EQUIVALENT TO HISTOLOGY IN THE DETECTION OF GLUTEN-FREE DIET EFFICACY
IN COELIAC DISEASE
Hadis Mirzaei, Caroline Fung, Rupert Leong
179.
EARLY CAPSULE ENDOSCOPY IN OBSCURE GASTROINTESTINAL BLEEDING LEADS TO HIGHER DIAGNOSTIC YIELD AND A
NEGATIVE CAPSULE STUDY IS A PREDICTOR OF LOW RE-BLEEDING RISK
Shanela Sooben, Dev Segarajasingam, Charlie Viiala
180.
SERVICE AND QUALITY IMPROVEMENT: �ENDOCLOT’ MODIFIED CARBON DIOXIDE DELIVERY SYSTEM ALLOWS SAFE AND
PROLONGED USE IN COMPLEX ACUTE SEVERE UPPER GASTROINTESTINAL HAEMORRHAGE
Danielle Ashe, Suresh Ponneswamy, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Alison Kenny, Tony Rahman, Ruth
Hodgson
200.
DIAGNOSTIC YIELD OF SUREPATHВ® IN SOLID PANCREATIC AND GIST LESIONS
Abdelrahim Azizi
216.
ENDOSCOPIC TREATMENT OF BARRETT’S OESOPHAGUS WITH DYSPLASIA OR INTRAMUCOSAL CARCINOMA: EXPERIENCE
AND OUTCOMES FROM AN AUSTRALIAN TERTIARY CENTRE
Niroshan Muwanwella, Sherman Picardo, Chiang Siah
222.
INTERNATIONAL MULTICENTRE EXPERIENCE WITH PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR THE TREATMENT OF
SPASTIC OESOPHAGEAL DISORDERS REFRACTORY TO MEDICAL THERAPY
Vivek Kumbhari, Ahmed Messallam, Manvi Solanki, Manabu Onimaru, Payal Saxena, Ezra Teitelbaum, Michael Ujiki,
Matthew Gitelis, Rani Modayil, Eric Hungness, Stavros Stavropoulos, Mohamad El Zein, Hironari Shiwaku, Rastislav
Kunda, Alessandro Repici, Hitomi Minami, Philip Chiu, Jeffery Ponsky, Amit Maydeo, Haruhiro Inoue, Mouen Khashab
238.
FIRST AUSTRALIAN EXPERIENCE USING THE NOVEL INSTINCT ENDOSCOPIC CLIP: A STUDY OF USABILITY AND OUTCOMES
Emma Bayly, Jeremy Dwyer, Alan Moss
246.
BALLOON ASSISTED CHOLANGIOSCOPY: WHICH OPTICAL FEATURES DIFFERENTIATE BETWEEN BENIGN AND NEOPLASTIC
LESIONS?
Mathew Keegan, Peter Lim, Rajvinder Singh, Philip Craig
251.
PROSPECTIVE MULTICENTRE INTERNATIONAL STUDY ON EUS-GUIDED BILIARY DRAINAGE FOR PATIENTS WITH DISTAL
MALIGNANT BILIARY OBSTRUCTION AND FAILED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP)
Vivek Kumbhari, Payal Saxena, Carlo Fabbri, Ahmed Mesallam, Shyam Varadarajulu, Ilaria Tarantino, Rani Modayil,
Stavros Stavropoulos, Manuel Perez-Miranda, Joseph Romagnuolo, Vinay Dhir
256.
PANCREATIC SEROUS CYSTADENOMA-RELATED MORTALITY IS ALMOST NIL - RESULTS OF A MULTINATIONAL STUDY
UNDER THE AUSPICES OF THE INTERNATIONAL ASSOCIATION OF PANCREATOLOGY AND THE EUROPEAN PANCREATIC CLUB
Yawei Tang, Rupert Leong, Raghubinder Gill, Benedicte Jais, Phillipe Levy
258.
A NOVEL FLEXIBLE 19-GAUGE EUS-FNA NEEDLE APPEARS SAFE AND EFFECTIVE FOR INTERVENTIONAL EUS: AN
INTERNATIONAL MULTICENTRE EXPERIENCE
Vivek Kumbhari, Payal Saxena, Irene PeГ±as, Carlos De la Serna, Alan Tieu, Manvi Solanki, Manie Juneja, Faud Maufa,
Nadim Haddad, Sandeep Krishnan, Susana Gonazalez, Peter Renny, Christopher DiMaio, Jonathan Buscaglia, Manuel
Perez-Miranda, Mouen Khashab
21
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
22
266.
UTILITY OF ENDOSCOPIC ULTRASONOGRAPHY FOR EVALUATION AND SURVEILLANCE OF GASTRIC SUBEPITHELIAL
TUMOURS
Matthew Smith, Andre Chong, Marcus Chin, Simon Edmunds, Spiro Raftopoulos, Ian Yusoff, Dev Segarajasingam, Chiang
Siah
269.
GASTRIC GASTROINTESTINAL STROMAL TUMOURS (GISTS): TO NEEDLE OR NOT?
Matthew Smith, Andre Chong, Marcus Chin, Simon Edmunds, Spiro Raftopoulos, Ian Yusoff, Dev Segarajasingam, Chiang
Siah
270.
COMPARISON OF TWO NEEDLE ASPIRATION TECHNIQUES FOR ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE
ASPIRATION (EUS-FNA) IN SOLID PANCREATIC LESIONS: A PROSPECTIVE MULTICENTRE STUDY
Payal Saxena, Vivek Kumbhari, Mohamad El Zein, Ahmed Abdelgelil, Sepiedeh Besharati, Ahmed Mesallam, Tyler
Stevens, Eun Ji Shin, Vikesh Singh, Anne Marie Lennon, Marcia Canto, Mouen Khashab
272.
LOW INCIDENCE OF RECURRENCE OF PIECEMEAL RESECTED LARGE COLONIC POLYPS USING UNDERWATER EMR
Rees Cameron
273.
EFFICACY AND SAFETY OF ERCP PERFORMED BY A NEWLY TRAINED AUSTRALIAN INTERVENTIONAL ENDOSCOPIST
INCORPORATING MODERN TECHNIQUES TO ENHANCE CANNULATION AND PREVENT PANCREATITIS
Shan Kannuthurai, Jeremy Dwyer, Alan Moss
274.
INTERVENTIONAL DEEP ENTEROSCOPY IN PATIENTS WITH SURGICALLY ALTERED ANATOMY USING STANDARD
ENDOSCOPES AND A THROUGH-THE-SCOPE-BALLOON
Vivek Kumbhari, Payal Saxena, Andrew Storm, Manvi Solanki, Patrick Okolo III
287.
RAPID PROGRESSION FROM LGD TO HGD BARRETT �S – MYTH OR REALITY
Puneet Mahindra, Richard Williams, Paul Desmond, Andrew Taylor
302.
ENDOSCOPIC RESECTION OF SPORADIC DUODENAL ADENOMAS IS SAFE AND EFFECTIVE - A PROSPECTIVE EXPERIENCE
FROM A TERTIARY ENDOSCOPY CENTRE
Amir Klein, Farzan Bahin, Dhruv Nayyar, Khalid Rasouli, Golo Ahlenstiel, Eric Lee, Stephen Williams, Michael Bourke
304.
ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER
Nicholas Tutticci, Amir Klein, Farzan Bahin, Dhruv Nayyar, Eric Lee, Michael J Bourke
315.
BIODEGRADABLE STENT PLACEMENT TO TREAT POST BARIATRIC SURGERY LEAKS: A CASE SERIES
Estella Johns, Patrick Walsh
319.
EFFICACY OF VISCOUS BUDESONIDE SLURRY IN THE PREVENTION OF OESOPHAGEAL STRICTURE FORMATION
POST ENDOSCOPIC MUCOSAL RESECTION OF BARRETT’S OESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND EARLY
OESOPHAGEAL ADENOCARCINOMA
Farzan Bahin, Mahesh Jayanna, Stephen Williams, Lee Eric, Song Min, Rebecca Sonson, Michael Bourke
324.
UNIFORMITY OF PRACTICE IN THE ABSENCE OF AN EVIDENCE BASE: OVERUSE OF PPI INFUSIONS IN A TERTIARY REFERRAL
CENTRE
James Fulforth, Evan Newnham, John Lubel
327.
DIAGNOSTIC UTILITY OF ECHOTIP PROCORE 25-GAUGE NEEDLE FOR EUS-FNA OF CONSECUTIVE SOLID LESIONS OF THE GI
TRACT
Andrew St John, Nadia Maqboul, Saurabh Gupta
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
328.
COMPARISON OF THE HISTOPATHOLOGICAL EFFECTS OF TWO ELECTROSURGICAL CURRENTS IN AN IN-VIVO PORCINE
MODEL OF OESOPHAGEAL ENDOSCOPIC MUCOSAL RESECTION
Farzan F Bahin, Nicholas G Burgess, Shahrir Kabir, Rafael Perez-Dye, Vishnu Subramanian, Duncan J McLeod, Hema
Mahajan, Maria Pellise, Rebecca Sonson, Michael J Bourke
330.
LONG TERM OUTCOMES OF A PRIMARY COMPLETE ENDOSCOPIC RESECTION STRATEGY FOR BARRETT’S OESOPHAGUS
WITH HIGH-GRADE DYSPLASIA AND EARLY OESOPHAGEAL ADENOCARCINOMA
Farzan Bahin, Mahesh Jayanna, Luke Hourigan, Reginald Lord, Whiteman David, Stephen Williams, Eric Lee, Min Song,
Rebecca Sonson, Michael Bourke
334.
PATTERNS OF ASPIRIN USE IN THE COMMUNITY
Oyekoya Ayonrinde, Kavitha Subramaniam, Faye Latchmiah, Jacob Helenius, Kar Mun Ng, Meghan Kan, Katrina
Spilsbury, James Semmens, Aqif Mukhtar, Michael Leahy, John K Olynyk
HEPATOLOGY – CLINICAL
4.
LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW OF LONG-TERM QUALITY OF LIFE
Linda Yang, Leonard Shan, Akshat Saxena, David Morris
13.
THE PATTERN OF ALPHAFETOPROTEIN LEVEL HAS GREATER DIAGNOSTIC VALUE COMPARED TO ISOLATED VALUES IN
PREDICTING THE PRESENCE OF HEPATOCELLULAR CARCINOMA
Abhinav Vasudevan, Natalie Denyar, Kumanan Nalankilli, Anvesh Jackson, Cian Scanlon, Jarrod Greenhalgh, John Lubel
16.
A COMPARISON OF FIBROSCAN AND SHORT WAVE ELASTOGRAPHY PERFORMED DURING CONVENTIONAL
ULTRASONOGRAPHY TO ASSESS LIVER FIBROSIS
Lindsay Mollison, Laurens Manning, Chris Welman, Lachlyn Ayers, Crystal Connelly, John Olynyk, Muhammad Zubair,
Sam Galhenage, O T (Koya) Ayonrinde
19.
AN ELF SCORE OF >=9.8 CAN IDENTIFY ADVANCED FIBROSIS IN AUSTRALIAN PATIENTS WITH CHRONIC LIVER DISEASE
Kevin Fagan
45.
EPIDEMIOLOGIC TRENDS IN MORTALITY OF CIRRHOSIS IN THE INTENSIVE CARE UNIT: A LARGE, AUSTRALASIAN, MULTICENTRE COHORT
Avik Majumdar, Michael Bailey, William Kemp, Stuart Roberts, David Pilcher
54.
EFFECT OF METABOLIC SYNDROME ON PATIENTS WITH VIRAL HEPATITIS TREATED WITH LOCAL REGIONAL THERAPY FOR
HEPATOCELLULAR CARCINOMA
Fei Chen, Jacob George, Amany Zekry
55.
NON-ALCOHOLIC FATTY LIVER DISEASE INTERMITTENT FASTING TIME INTERVENTION (NIFTI): FASTING WITHOUT CALORIE
RESTRICTION IMPROVES HEPATIC TRANSIENT ELASTOGRAPHY, VISCERAL ADIPOSITY AND INSULIN RESISTANCE
COMPARED TO STANDARD CARE
Alexander Hodge, Alexandra Mack, Caroline Tuck, Jorge Tchongue, Darcy Holt, William Sievert, Gregory Moore
57.
PERCUTANEOUS THERMAL ABLATION FOR PRIMARY HEPATOCELULAR CARCINOMA: A SYSTEMATIC REVIEW AND METAANALYSIS
Mohamed Asif Chinnaratha, Ming-yu (Anthony) Chuang, Robert Fraser, Richard Woodman, Alan Wigg
23
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
24
58.
SUCCESSFUL EX-VIVO NORMOTHERMIC OXYGENATED MACHINE PERFUSION OF HUMAN DONOR LIVERS
Janske Reiling, DSR Lockwood, AH Simpson, CM Campbell, KR Bridle, N Santrampurwala, LJ Britton, DHG Crawford, CHC
Dejong, J Fawcett
59.
PREVALENCE OF BONE DISEASE IN CIRRHOSIS
Mohamed Chinnaratha, Rosemary McCormick, Rachel Wundke, Richard Woodman, Alan Wigg
60.
SERUM DICKKOPF-1, OSTEOPONTIN AND MIDKINE AS NOVEL BIOMARKERS FOR THE DIAGNOSIS AND PRE-CLINICAL
DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
Roslyn Vongsuvanh, Jacob George, Tristan Iseli, Simone Strasser, Geoffrey McCaughan, David van der Poorten
61.
NON-ALCOHOLIC FATTY LIVER DISEASE AND ALL-CAUSE AND CARDIOVASCULAR MORTALITY: A POPULATION BASED
COHORT STUDY
Suzanne Mahady, Germaine Wong, Robin Turner, Jonathan Craig, Jacob George
63.
CAFFEINE CONSUMPTION IS NOT ASSOCIATED WITH DISEASE SEVERITY IN NAFLD
David van der Poorten, Tommy Tran
64.
SIMPLE SERUM MARKERS MODELS ACCURATELY PREDICT LIVER RELATED SURVIVAL, COMPLICATIONS AND HCC IN
CHRONIC HCV INFECTION
Yi Huang, Leon Adams, Gerry MacQuillan, Enrico Rossi, Max Bulsara, Gary Jeffrey
65.
A NEW SERUM BIOCHEMICAL MODEL THAT ACCURATELY PREDICTS LIVER COLLAGEN PROPORTIONAL AREA
Yi Huang, Bastiaan de Boer, Leon Adams, Gerry MacQuillan, Enrico Rossi, Max Bulsara, Gary Jeffrey
68.
PREDICTORS OF ALCOHOL RECIDIVISM FOLLOWING LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE IN AN
AUSTRALIAN POPULATION
Dileep Mangira, Anthony Chuang, John Chen, Richard Woodman, Alan Wigg
72.
CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION HAS A HIGH MORTALITY AND IS REFRACTORY TO INTERFERON
THERAPY
Talal Valliani, Ramesh Paramsothy, Geoff McCaughan, Simone Strasser
98.
HIV IS ASSOCIATED WITH PROGRESSION OF LIVER STIFFNESS IN CHRONIC HEPATITIS C
Nicole Wong, Stuart Roberts, Paula Lewis, Eldho Paul, Kitson Matt, David Iser, William Kemp
107.
POST-PARTUM CARE OF WOMEN WITH HEPATITIS B AND THEIR BABIES
Stephanie Spring, Lukas Sahhar, Natassia Tan, Phil Ha, Vanessa Bull, William Birkett, Joseph Lewis, Emily Licklitter,
Trushna Trivedi, Suong Le, Anouk Dev
108.
EPIDEMIOLOGY AND OUTCOMES OF PRIMARY SCLEROSING CHOLANGITIS PATIENTS IN AN AUSTRALIAN COHORT
Ken Liu, Rosy Wang, Mark Wells, Simone Strasser, Geoff McCaughan, Crispin Corte, Rupert Leong
116.
VACCINATION AND OPPORTUNISTIC TESTING FOR HEPATITIS B VIRUS AMONGST RELATIVES, HOUSEHOLD AND SEXUAL
CONTACTS OF PATIENTS WITH CHRONIC HEPATITIS B
Vanessa Bull, Phil Ha, Natassia Tan, Lukas Sahhar, Stephanie Spring, Suong Le, Anouk Dev
121.
CONTRAST ENHANCED ULTRASOUND (CEUS) MAKES A SIGNFIICANT DIFFERENCE IN THE ASSESMENT OF INDETERMINATE
LIVER LESIONS - AN AUSTRALIAN TERTIARY CENTRE EXPERIENCE
Desmond Patrick, Niramjan Arachchi, Alan Moss, Ian Kronborg, Julian Nguyen
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
127.
HEPATITIS C TREATMENT AND PROGRESSION OF LIVER STIFFNESS IN AUSTRALIA, SUBSEQUENT TO THE INTRODUCTION OF
PROTEASE INHIBITORS
Yang Wu, Martin Weltman, Guy Eslick
133.
HEPATIC FIBROSIS IN AN ELDERLY POPULATION
Martin Veysey, Way Siow, Suzanne Niblett, Katrina King, Zoe Yates, Mark Lucock
135.
COMPARISON OF TRANSIENT ELASTOGRAPHY AND NAFLD FIBROSIS SCORE IN NON-ALCOHOLIC FATTY LIVER DISEASE
Yang Wu, Martin Weltman, Guy Eslick
136.
WHITE CELL COUNTS AND NON-ALCOHOLIC FATTY LIVER DISEASE
Martin Veysey, Way Siow, Suzanne Niblett, Katrina King, Zoe Yates, Mark Lucock
141.
COMPARISON OF NAFLD FIBROSIS SCORE (NFS) AND TRANSIENT ELASTOGRAPHY (FIBROSCANВ®), ALONE AND IN
COMBINATION, AS NON-INVASIVE METHODS FOR THE EVALUATION OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE
(NAFLD)
Edric Hee, William W. Kemp, Bastiaan de Boer, Jeffrey M. Hamdorf, Gerry C. MacQuillan, George Garas, Helena Ching,
Ross MacNicholas, Stuart K. Roberts, Matthew T. Kitson, Gary P. Jeffrey, Leon Adams
145.
THERAPEUTIC ABDOMINAL PARACENTESIS IN AN AMBULATORY SETTING: IS ROUTINE BLOOD CULTURE BOTTLE COCULTURE NECESSARY?
Thomas Goodsall, Mahesh Menon, Steven Bollipo, John Ferguson
148.
DEVELOPMENT OF AUTOIMMUNE TYPE I DIABETES MELLITUS DURING TREATMENT WITH PEGINTERFERON AND RIBAVIRIN
FOR CHRONIC HEPATITIS C- A TERTIARY CENTRE EXPERIENCE
Samarth Rao, Wendy Cheng
149.
CANCER REGISTRIES UNDERESTIMATE HEPATOCELLULAR CARCINOMA INCIDENCE: AN INDEPENDENT POPULATION-BASED
EPIDEMIOLOGICAL STUDY
Thai Hong, Alexander Thompson, Paul Gow, Michael Fink, Anouk Dev, Virginia Knight, Marno Ryan, Ian Kronborg,
Niranjan Arachchi, Stuart Roberts, William Kemp, Amanda Nicoll, John Lubel, Helen Farrugia, Vicky Thursfield, Paul
Desmond, Sally Bell
153.
TREATMENT SAFETY AND EFFICACY OF BOCEPREVIR-BASED TRIPLE THERAPY IN GENOTYPE 1 HEPATITIS C: THE
AUSTRALIAN MULTICENTRE BOCEPREVIR REAL WORLD EXPERIENCE (SABRE-C)
Anouk Dev, Joanne Mitchell, Kevan Polkinghorne, Richard Skoien, Katherine Stuart, Wendy Cheng, Alice Lee, Miriam
Levy, John Lubel, Saroja Nazareth, Sherryne Warner, Alan Wigg, Stuart Roberts
154.
HOSPITAL UTILIZATION IN PATIENTS WITH LIVER CIRRHOSIS AFTER ENROLMENT TO THE CHRONIC LIVER FAILURE
PROGRAM
Su Yin Lau, Richard Woodman, Rachel Wundke, Rosemary McCormick, Alan Wigg
155.
ARE WE DOING ENOUGH? SCREENING AT-RISK PATIENTS FOR HEPATITIS B IN INFLAMMATORY BOWEL DISEASE CLINICS
Edward Hao Jun Tsoi, Cheng Yee Goh, Niranjana Parthasarathy, Kaye Marion, Charys McNab, Simon Glance, Christopher
Leung
158.
IMPLICATIONS OF TREAT NOW VERSUS WAITING FOR NEWER THERAPEUTIC REGIMENS IN CHRONIC HEPATITIS C
Gauri Mishra
25
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
26
169.
ANTIMITOCHONDRIAL ANTIBODIES (AMA) AND PRIMARY BILIARY CIRRHOSIS (PBC) – THE ST. VINCENT’S EXPERIENCE 2003 2013
Manjeet Sandhu, Alexander Thompson, Wanyuan Cui, Paul Desmond, Sally Bell, Marno Ryan, Barbara Demediuk, Robert
Chen, David Iser, Gideon Shaw, Aaaron Bloch, Tin Nguyen
173.
CASE CONTROL COHORT STUDY OF CANCER RATES IN SYNCHRONOUS PRIMARY SCLEROSING CHOLANGITIS AND
INFLAMMATORY BOWEL DISEASE VERSUS PATIENTS WITH INFLAMMATORY BOWEL DISEASE ALONE
Ken Liu, Rosy Wang, Viraj Kariyawasam, Paul Lunney, Mark Wells, Simone Strasser, Geoff McCaughan, Crispin Corte,
Rupert Leong
183.
INTEGRATED SAFETY ANALYSIS OF SOFOSBUVIR-BASED HCV TREATMENT REGIMENS FROM PHASE 3 STUDIES
Alexander Thompson, S Gordon, W Towner, A Aggarwal, J Ma, J McNally, LM Stamm, DM Brainard, WT Symonds, JG
McHutchison, N Bellos, K Tashima, N Afdhal
188.
SOFOSBUVIR-BASED REGIMENS ARE ASSOCIATED WITH HIGH SVR RATES ACROSS GENOTYPES AND AMONG PATIENTS
WITH MULTIPLE NEGATIVE PREDICTIVE FACTORS
Alexander Thompson, GR Foster, SI Strasser, C Christensen, J Ma, N Bekele, DM Brainard, WT Symonds, JG McHutchison,
B Conway, I Crespo, S Zeuzem
197.
A COMBINED RULE BASED ON HBSAG LEVELS AND HBV DNA LEVELS PREDICTS RISK OF HBV REACTIVATION IN PATIENTS IN
THE IMMUNE CONTROL PHASE OF CHB
Gareth Burns, Jacinta Holmes, Rimma Goldberg, Rebecca Trethowan, Avelyn Wong, Oliver Cronin, Niketh Kuruvilla, Tin
Nguyen, Raymond Shaw, Robert Chen, Barbara Demediuk, Sally Bell, Stephen Locarnini, Scott Bowden, Paul Desmond,
Alexander Thompson
198.
LONG TERM FOLLOW-UP OF PATIENTS TREATED WITH SOFOSBUVIR IN THE PHASE 3 STUDIES FISSION, POSITRON, FUSION
AND NEUTRINO
Wendy Cheng, S Shafran, K Beavers, H Mo, J McNally, DM Brainard, WT Symonds, M Chojkier, A Mangia, C Schwabe
199.
UNDERSTANDING THE PHASES OF CHRONIC HEPATITIS B; THE PROBLEM AND A NOVEL SOLUTION USING RENAMED
PHASES, THE HEPATITIS B BEAR AND A VIDEO (SEE “ UNDERSTANDING HEPATITIS B “ ON YOUTUBE)
Heidi Lord, Carla Treloar, Elena Cama, Jamee Newland, Miriam Levy
202.
PAIN CONTROL AND PREVENTION OF ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
Vanessa Weerasinghe Mudiyansalage, Malcolm Hogg, Chatura Jayasekera, Amanda Nicoll
203.
LIVER ULTRASOUND DOES NOT ACCURATELY PREDICT TRANSIENT ELASTOGRAPHY DIAGNOSED CIRRHOSIS
Charitha Ranaweera, Oyekoya Ayonrinde, Mollison Lindsay, Sam Galhenage, John Olynyk
207.
SOFOSBUVIR IN COMBINATION WITH PEG IFN AND RIBAVIRIN FOR 12 WEEKS PROVIDES HIGH SVR RATES IN HCV-INFECTED
GENOTYPE 2 OR 3 TREATMENT EXPERIENCED PATIENTS WITH AND WITHOUT COMPENSATED CIRRHOSIS: RESULTS FROM
THE LONESTAR-2 STUDY
Stephen Pianko, E Lawitz, F Poordad, DM Brainard, RH Hyland, D An, WT Symonds, JG McHutchison
209.
THE LANDSCAPE OF HEPATITIS B WOMEN IN A SINGLE CENTRE
Enoka Gonsalkorala, Miriam Levy, Vi Nguyen, Carina Burns, Anne Glass
210.
HEPATITIS C MANAGEMENT EXPERIENCE IN A REGIONAL HOSPITAL
Mohammed Alansari, C. Schepisi, K. Simpson, L. Johnston, C. Sainsbury
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
211.
ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTOGRAPHY HAS A WEAK CORRELATION WITH CHILD PUGH GRADE AND
THE PRESENCE OF COMPLICATIONS
David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Alexandra Gorelik, Danny Liew, Amanda Nicoll
212.
INCIDENCE AND RISK FACTORS ASSOCIATED WITH VOLATILE ANAESTHETIC DRUG INDUCED LIVER INJURY (VALDA
PROJECT): INTERIM ANALYSIS
Nicholas Hannah, Brad Hockey, David Moore, Jonathan Lin, Dolores Njoku, Adam Doyle, Fransesco Amico, Alexandra
Gorelik, Danny Liew, John Halliday, Amanda Nicoll
214.
A QUALITATIVE ASSESSMENT OF KNOWLEDGE, PERCEPTION AND HEALTH EXPECTATIONS AMONGST PATIENTS WITH
CHRONIC HEPATITIS B
Natassia Tan, Vanessa Bull, Phil Ha, Lukas Sahhar, Stephanie Spring, Suong Le, Anouk Dev
218.
HEPATIC FIBROSIS REGRESSION IN HEPATITIS B COHORT ON LONG-TERM ORAL ANTIVIRAL THERAPY
Christine Verdon, Stephen Oh, Christopher Kiely, Ross Hansen, Jocelyn Schramko, Venessa Pattullo, Brett Jones
221.
SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING
FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION
Simone Strasser, X Forns, M Prieto, M Charlton, JG McHutchison, WT Symonds, J Denning, T Brandt-Sarif, P Chang, V
Kivett, TF Baumert, A Coilly, F Habersetzer
230.
REAL WORLD EFFICACY AND SAFETY WITH DIRECT ACTING ANTIVIRAL DRUGS IN CHRONIC HEPATITIS C - WESTERN
AUSTRALIAN EXPERIENCE
Samarth Rao, Wendy Cheng
231.
CT HEPATIC ANGIOGRAPHY VERSUS BIOPSY IN THE DIAGNOSIS OF RADIOLOGIC ATYPICAL HEPATOCELLULAR CARCINOMA –
AN EVALUATION OF REAL LIFE PRACTICE
Desmond Patrick, Stephen Bloom, Manfred Spanger, Vivek Ramachandran, John Lubel
235.
NON-INVASIVE BIOMARKERS ARE SUPERIOR TO CLINICAL MEASURES IN PREDICTING HEPATIC DECOMPENSATION AFTER
LIVER RESECTION
James Thomas, Raj Ashok, Uthayanam Chelvaratnam, Marrianne Black, Linda Fletcher, Caroline Tallis, Gerald Holtmann,
Jonathan Fawcett, Katherine Stuart
248.
ULTRASOUND (US) GUIDED PERCUTANEOUS LIVER BIOPSY OUTCOMES AT A TERTIARY HOSPITAL – A COMPARISON
BETWEEN GASTROENTEROLOGY ADVANCED TRAINEE VERSUS RADIOLOGIST-PERFORMED PROCEDURES
Sivathasan Sellathurai, Gregory Carter, Aidan Foy, Lay Gan, Simon King, Robert Foster
253.
ACOUSTIC RADIATION FORCE IMPULSE IMAGING (ARFI) IN THE ASSESSMENT OF LIVER FIBROSIS; AN ANALYSIS OF
PERFORMANCE WITHIN A �REAL-LIFE’ AUSTRALIAN SETTING
David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Michael Christie, Alexandra Gorelik, Danny Liew,
Amanda Nicoll
254.
GOOD TRANSIENT ELASTOGRAPHY INTER-OBSERVER REPRODUCIBILITY IN A NURSE-LED FIBROSCAN CLINIC AT A SINGLE
TERTIARY CENTRE
Nadine Leembruggen, Saroj Nazareth, Terri Budge, Sook-Ling Chen, Eng Gan, Cheng Wendy
260.
MICROBIAL BURDEN IS ASSOCIATED WITH CLINICAL OUTCOMES AND REDUCED ASCITES INNATE IMMUNE CELLS IN NONINFECTED ASCITES
Katharine Irvine, Kevin Fagan, Michelle Melino, Elizabeth Powell
43
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
44
262.
PREDICTORS OF INPATIENT MORTALITY IN CIRRHOTICS IN THE INTENSIVE CARE UNIT: A TASMANIAN EXPERIENCE
Sern Wei Yeoh, Karen Wills, Ted Stoklosa, Karl Vaz, Shamim Samedani, Maneesha Bhullar, Rajesh Bhatia
268.
INTER-OPERATOR CONCORDANCE IN ACOUSTIC RADIATION FORCE IMPULSE IMAGING (ARFI); A PRACTICAL ROLE FOR
MULTIPLE OPERATORS TO IMPROVE DIAGNOSTIC PERFORMANCE
David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Michael Christie, Alexandra Gorelik, Danny Liew,
Amanda Nicoll
277.
FALSE POSITIVE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN A MULTIDISCIPLINARY LIVER CLINIC
Toni Hampe, Betty Wu, Francis Chu, John Freiman
278.
WEIGHT GAIN AFTER LIVER TRANSPLANT OCCURS EARLY AND IS UNRELATED TO THE EMOTIONAL STATE AND EATING
BEHAVIOURS USUALLY SEEN IN OBESITY
Simone McCoy, Katrina Campbell, Maree Jarrett, Jonathan Fawcett, Graeme Macdonald, Ingrid Hickman
280.
EVALUATION OF PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH HCC UNDERGOING TREATMENT WITH
TRANSARTERIAL CHEMOEMBOLISATION: IMPORTANCE OF CLIP RATHER THAN HAP SCORE
Christabel Kelly, Pamela Crest, Eldho Paul, Paula Lewis, William Kemp, Stuart Roberts
283.
IMPROVED PREDICTION OF LIVER FIBROSIS AND PROBABILITY OF NASH IN PATIENTS WITH NAFLD BY COMBINING LIVER
STIFFNESS WITH CLINICOPATHOLOGICAL AND BIOMARKER MEASUREMENTS
Gan Lay Theng, Lay T Gan, Bruce Shadbolt, Vincent Wong, Leon Adams, Teddi Dwyer, Henry Chan, Narci Teoh, Shiv
Chitturi, Geoff Farrell
295.
PERCUTANEOUS TRANSHEPATIC VARICEAL EMBOLISATION - FIRST CASE REPORTS IN AN AUSTRALIAN SETTING
Aviv Pudipeddi, Mark Danta, Robert Feller, Arti Rattan, Joga Chaganti
301.
PRE-OPERATIVE CARDIORESPIRATORY FITNESS AND POST-OPERATIVE CARDIOMETABOLIC DISEASE IN LIVER TRANSPLANT
RECIPIENTS
Matthew Wallen, Jeff Coombes, Graeme Macdonald, Aidan Woodward, Tina Skinner
309.
NONINVASIVE TESTING INCLUDING INDOCYANIN GREEN CLEARANCE IN PREDICTION OF CLINICALLY SIGNIFICANT PORTAL
HYPERTENSION
Sarah Gardner
325.
THE CHANGING RISK FACTOR PROFILE OF HEPATOCELLULAR CARCINOMA: EXPERIENCES FROM A WESTERN AUSTRALIAN
TERTIARY CENTRE
Sherman Picardo, Jee Kong, Lorenzo Tarqunio, Nick Kontorinis, Wendy Cheng
326.
EUS-GUIDED BILIARY DRAINAGE PERFORMED BY HEPATOGASTROSTOMY VS. CHOLEDOCHODUODENOSTOMY: AN
INTERNATIONAL MULTICENTER COMPARATIVE STUDY IN 150 PATIENTS
Vivek Kumbhari, Payal Saxena, Yousuke Nakai, Rani Modayil, Carlos De La Serna, Kazuo Hara, Stavros Stavropoulos,
Manuel Perez-Miranda, Vinay Dhir, Do Hyun Park, Mouen Khashab
329.
SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND
WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY
Geoffrey McCaughan, N Afdhal, G Everson, JL Calleja, WT Symonds, J Denning, L McNair, JG McHutchison, S Arterburn,
M Charlton, R Reddy, T Asselah, E Gane, X Forns
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
332.
REGRESSION OF ADVANCED FIBROSIS FOLLOWING VIROLOGICAL RESPONSE TO ANTI-HCV THERAPY
Marianne Martinello, Dianne How-Chow, Mark Danta, Gail Matthews, Greg Dore
333.
SAFETY AND EFFICACY OF TELAPREVIR AND BOCEPREVIR IN THE “REAL WORLD”: AN AUSTRALIAN EXPERIENCE
Marianne Martinello, Dianne How-Chow, Mark Danta, Gail Matthews, Greg Dore
IBD – CLINICAL
7.
INCIDENCE OF PAEDIATRIC IBD IN NEW SOUTH WALES, AUSTRALIA INCREASES THROUGH 1968-2013
Cheng Hiang Lee, Rupert W Leong, Edward V O’Loughlin, Kevin J Gaskin
15.
CAECAL TUBERCULOSIS MASQUEADING AS INFLAMMATORY BOWEL DISEASE
Kate Napthali, Robert Foster
25.
DOES LYMPHOPENIA OR MACROCYTOSIS REFLECT THERAPEUTIC 6-THIOGUANINE LEVELS IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE TREATED WITH AZATHIOPRINE OR 6-MERCAPTOPURINE?
Neel Heerasing, Jer Fuu Ng, Damian Dowling, Christopher Hair
51.
ACCELERATED 1-HR INFLIXIMAB INFUSIONS ARE SAFE AND COST EFFECTIVE IN PATIENTS WITH INFLAMMATORY BOWEL
DISEASE
Guang Chen, Payal Saxena, Glen Collins, Rupert Leong
77.
ADALIMUMAB ACHIEVES EFFICACY IN MUCOSAL HEALING REGARDLESS OF BASELINE DISEASE SEVERITY IN PATIENTS
WITH CROHN’S DISEASE: DATA FROM EXTEND
Nicolas Martin, William Sandborn, Douglas Wolf, Jean-Frederic Colombel, Julian Panes, Samantha Eichner, Annalisa
Iezzi, Qian Zhou, Anne Robinson, Roopal Thakkar
82.
INFLIXIMAB SALVAGE OUTCOMES IN ACUTE SEVERE COLITIS IN A SINGLE AUSTRALIAN INFLAMMATORY BOWEL DISEASE
CENTRE: HIGHLY EFFICACIOUS, COST EFFECTIVE AND PBS LISTED
Abhinav Vasudevan, Jarrod Greenhalgh, Cian Scanlon, Asiri Arachchi, Ramessh Ranjan, Elliott Freeman, Sanjay
Nandurkar, Daniel van Langenberg
85.
THIRD PARTY FUNDING FOR FAECAL CALPROTECTIN IS LIKELY TO REDUCE COLONOSCOPY USAGE IN AUSTRALIA:
GASTROENTEROLOGISTS’ USE AND KNOWLEDGE OF ITS ROLE IN CLINICAL PRACTICE
Omar Elnawsra, Ian Fok, Susan Connor, Miles Sparrow, Peter Gibson, Jane Andrews
86.
OUTCOMES OF SALVAGE THERAPY FOR ACUTE SEVERE COLITIS TREATMENT IN A SINGLE TERTIARY CENTRE: INFLIXIMAB V.
CYCLOSPORINE
Sophie Shepherd, Emily K Wright, Jacinta A Holmes, Steven J Brown, Mark Lust, Michael A Kamm, Sally J Bell, William
Connell
90.
ANTI-TNF THERAPY USE IN PREGNANT PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
Christopher Kiely, Kavitha Subramanian, Paul Pavli
95.
FAECAL CALPROTECTIN – IMPACT ON TIMING OF COLONOSCOPY IN IBD PATIENTS
Ria Kanazaki, Thomas Lee, Claudia Rogge, Arthur Grillas, Jenny Roberts, Jennifer McDonald, Hung Chieng
102.
MEDICATION ADHERENCE IN TRANSITIONAL INFLAMMATORY BOWEL DISEASE PATIENTS: A MULTI-CENTRE PILOT STUDY
Jayson Jeganathan, Cheng Hiang Lee, Antony Rahme, Darren Tiao, Celine Weston, Shoma Dutt, Annabel Magoffin, Vu
Kwan, Peter Katelaris, Christian Selinger, Kevin Gaskin, Ted O’Loughlin, Rupert Leong
45
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
46
105.
RATIONALE, STUDY DESIGN AND INTERIM DATA FROM THE ALIGN STUDY: A MULTI-COUNTRY, CROSS-SECTIONAL,
EPIDEMIOLOGICAL STUDY EVALUATING BELIEFS AND CONCERNS ABOUT SYSTEMIC MEDICATION IN 6 CHRONIC
INFLAMMATORY DISEASES
Nicolas Martin, Pierre Michetti, John Weinman, Ulrich Mrowietz, Josef Smolen, Dieter Schremmer, Jingdong Chao, Nicole
Selenko-Gebauer
109.
IMPACT OF TARGETED PHARMACIST COUNSELLING INTERVENTION ON IBD MEDICATION ADHERENCE
Darren Tiao, Jayson Jeganathan, Andy Chen, Jeff Chang, Christian Selinger, Rupert Leong
114.
SEX-RELATED DIFFERENCES IN DISEASE COURSE AND PATIENT OUTCOME IN THE SYDNEY IBD COHORT
Paul Lunney, Viraj Kariyawasam, Rosy Wang, Kate Middleton, Tony Huang, Christian Selinger, Jane Andrews, Peter
Katelaris, Rupert Leong
115.
ADALIMUMAB AND INFLIXIMAB LEVELS IN NEONATES CORRELATE WITH DURATION OF TREATMENT IN PREGNANCY (ERA
STUDY)
Mette Julsgaard, Lisbet A Christensen, Peter R Gibson, Jan Fallingborg, Richard Gearry, Alissa Walsh, William Connell,
Jens Kjeldsen, Miles P Sparrow, Graham Radford-Smith, Jane M. Andrews, Ian Lawrence, Signe Wildt, Gregory T Moore,
Lise Svenningsen, Ourania Rosella, Anne Grosen, Sally J Bell
122.
METHOTREXATE CAN NAUSEATE, MORE THAN WE ANTICIPATE : CAN WE ALEVIATE (IN IBD)?
Desmond Patrick, Lauren Beswick, Daniel van Langenberg
124.
THE FIRST PROSPECTIVE AUSTRALIAN POPULATION-BASED NATURAL HISTORY STUDY OF NEWLY DIAGNOSED IBD
IDENTIFIES FREQUENT USE OF IMMUNOMODULATORS AND LOW SURGERY RATES
Ola Niewiadomski, Corrie Studd, Chris Hair, Wilson Jarrad, Nik Ding, Neel Heerasing, Alvin Ting, John McNeill, Ross
Knight, Paul Dabkowski, Emily Prewett, Sina Alexander, Damian Dowling, Ben Allen, Benjamin Popp, Paul Desmond,
William Connell, Sally Bell
125.
SOCIAL FACTORS THAT AFFECT ATTENDANCE RATES IN A METROPOLITAN INFLAMMATORY BOWEL DISEASE CLINIC
Cheng Yee Goh, Edward Hao Jun Tsoi, Charys McNab, Alvin Chung, Simon Glance
140.
THE EFFECTS OF VITAMIN D DEFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Amanda Lim, Soong-Yuan Ooi, Robert Bryant, CG Schultz, Charlotte Goess, JC Hughes, Dylan Bartholomeusz, Jane M
Andrews
144.
THE UTILITY OF MAGNETIC RESONANCE ENTEROGRAPHY IN DIAGNOSIS AND MANAGEMENT CHANGES IN CROHN’S
DISEASE
Chamara Basnayake, Gregory Moore
146.
INFLIXIMAB VERSUS CYCLOSPORINE IN SEVERE, STEROID-REFRACTORY ULCERATIVE COLITIS; A COMPARISON OF CLINICAL
OUTCOMES
Matija Radojcic, Finlay Macrae, Bernadette Viney
151.
THIOPURINE PRESCRIBING AND MONITORING BEHAVIOUR, INCLUDING METABOLITES TESTING AND ALLOPURINOL COTHERAPY: AN AUSTRALIAN PERSPECTIVE FROM 2008 TO 2013
Kenny Ching Pan Sze, Amanda Siriwardana, Wa Sang Watson Ng, Susan Jane Connor, Alexandra Sechi
156.
LONG-TERM SAFETY OF ONCE-DAILY MULTIMATRIX MESALAZINE: A POOLED CLINICAL TRIALS ANALYSIS
Susana D. Silva Sanchez, Hong Wan, Paul Streck, Deborah Willshire, Jeffrey B. Raskin
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
157.
THE EFFECTIVENESS OF SHORT-TERM AND LONG-TERM DAILY TREATMENT WITH MULTIMATRIX MESALAZINE ON
IMPROVING WORK-RELATED OUTCOMES IN ADULT PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS
Deborah Willshire, Mary Kaye Willian, Aaron Yarlas, Ashish V. Joshi
161.
TRANSITION IBD PATIENTS: A CHALLENGING AND COMPLICATED POPULATION
Matthew Choy, Alexandra Murphy, Aaron Bloch, Alex Thompson, Mark Lust, Steven Brown, Emily Wright, Michael Kamm,
George Alex, William Connell, Sally Bell
164.
CUTANEOUS MANIFESTATIONS OF ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) THERAPY IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE (IBD): A CASE SERIES
Faseeha Peer, Kavitha Subramaniam, Paul Pavli
167.
FORWARD-VIEWING COLONOSCOPY VERSUS FULL-SPECTRUM ENDOSCOPY (FUSE) FOR DYSPLASIA DETECTION WITH AND
WITHOUT CHROMOENDOSCOPY IN INFLAMMATORY BOWEL DISEASES: A PROSPECTIVE, RANDOMIZED-ORDER, CROSSOVER
TANDEM SURVEILLANCE COLONOSCOPY STUDY
Marie Ooi, James Panetta, Corte Crispin, Rupert Leong
191.
IS GEOGRAPHIC VARIABILITY OF INCIDENCE AND PREVALENCE OF CROHN’S DISEASE LINKED TO HELICOBACTER PYLORI?
AN ECOLOGIC STUDY
Gerald Holtmann, Ayesha Shah, Nicholas Talley, Marjorie Walker, Natasha Koloski, Erin Shanahan, Mark Morrison, Daniel
Burger, Jane Andrews, Michael McGuckin, Mike Jones
192.
HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATES CORRELATE WITH INCREASED DISEASE ACTIVITY, AND ARE
USEFUL IN ASSESSING ADHERENCE
Mark Ward, Fong Steven, Ikram Nasr, Rishi Goel, Kamal Patel, Monica Arenas Hernandez, Antony Marinaki, Jeremy
Sanderson, Peter Irving
217.
THIOPURINE METABOLITE MONITORING IN INFLAMMATORY BOWEL DISEASE (IBD): A RETROSPECTIVE OBSERVATIONAL
STUDY EVALUATING THE LONGER-TERM OUTCOMES (GREATER THAN OR EQUAL 12 MONTHS) OF METABOLITE LEVEL LED
CLINICAL MANAGEMENT – PRELIMINARY FINDINGS
Soong-Yuan Ooi, Jane Andrews, Susan Connor, Peter Bampton, Michael Gounder, Rachel Grafton, Peta Leach, Watson Ng
223.
IMPAIRED MUCOSAL PERMEABILITY UNDERLIES ONGOING IRRITABLE BOWEL SYNDROME-LIKE SYMPTOMS, IN PATIENTS
WITH INFLAMMATORY BOWEL DISEASE WHO HAVE ACHIEVED MUCOSAL HEALING
Jeff Chang, Matthew Ip, Michael Yang, Brendon Wong, Mehreen Arshi, Tri Phan, Rupert Leong
282.
POOR INFLAMMATORY BOWEL DISEASE-RELATED KNOWLEDGE IN MIDDLE EASTERN AND CAUCASIAN PATIENTS IS
ASSOCIATED WITH A KNOWLEDGE DEFICIT GRADIENT
Rhys Butcher, Crispin Corte, Gavin Barr, Grace Chapman, James Cowlishaw, David Brian Jones, Peter Katelaris, Charles
McDonald, John McLaughlin, Simon Campbell, Rupert Leong
286.
LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH INFLIXIMAB OR ADALIMUMAB IN AN
AUSTRALIAN REGIONAL CENTRE
Jeremy Dwyer, Diane Lim, Brent Mitchell
291.
COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) USE FOR INFLAMMATORY BOWEL DISEASE IS COMMON IN BOTH
MIDDLE EASTERN AND CAUCASIAN PATIENTS
Rhys Butcher, Crispin Corte, Gavin Barr, Grace Chapman, James Cowlishaw, David Brian Jones, Peter Katelaris, Charles
McDonald, John McLaughlin, Simon Campbell, Rupert Leong
47
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
297.
INFLIXIMAB INFUSION PROTOCOLS ARE TIME CONSUMING AND SEVERE INFUSION REACTIONS ARE RARE - IS IT TIME FOR
CHANGE?
Lauren Beswick, Lionel Soh, Anne McFarlane, Daniel van Langenberg
298.
REINDUCTION OF ADALIMUMAB AND INFLIXIMAB AFTER SECONDARY LOSS OF RESPONSE IN AN AUSTRALIAN IBD CENTRE:
AN EFFECTIVE STRATEGY
Belinda Jackson, Daniel Van Langenberg, Anne McFarlane
305.
CONSISTENTLY HIGH C REACTIVE PROTEIN AND PLATELET COUNT ARE ASSOCIATED WITH DEVELOPMENT OF PERIANAL
FISTULAE IN PATIENTS WITH CROHN’S DISEASE
James Irwin, Emma Ferguson, Lisa Simms, Katherine Hanigan, Graham Radford-Smith
312.
GENETIC ANALYSIS OF ESCHERICHIA COLI, FOCUSING ON ADHERENT, INVASIVE E. COLI ISOLATED FROM CROHN’S DISEASE
PATIENTS
Claire O’Brien, Paul Pavli, David Gordon
314.
CONSISTENTLY LOW HAEMOGLOBIN LEVEL, LOW ALBUMIN LEVEL AND HIGH PLATELET COUNT ARE ASSOCIATED WITH
SUBSEQUENT OBJECTIVE POOR OUTCOME IN PATIENTS WITH CROHN’S DISEASE
James Irwin, Emma Ferguson, Lisa Simms, Katherine Hanigan, Graham Radford-Smith
316.
HLA B27 IN CROHN’S DISEASE
Katerina Liew, Graham Radford-Smith
331.
PREVALENCE AND OUTCOMES OF CLOSTRIDIUM DIFFICILE INFECTION IN ADULT INFLAMMATORY BOWEL DISEASE PATIENTS
COMPARED TO AGE AND SEX MATCHED CONTROLS: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE
Desmond Patrick, Daniel Van Langenberg
337.
HOSPITALIZATION AND TREATMENT COSTS FOR ACUTE, SEVERE, STEROID-REFRACTORY ULCERATIVE COLITIS: INFLIXIMAB
BEATS CICLOSPORIN
Graham Radford-Smith, Phoebe Thwaites, James Irwin, Nicole Walker, Anna McMahon, Karen Sewell, Anthony Croft,
David Clark, Mariko Howlett
LUMINAL CLINICAL
48
5.
SIDE EFFECTS ARE SIDE ISSUES: COMPLETENESS OF REPORTING OF HARMS AMONG SYSTEMATIC REVIEWS IN
GASTROENTEROLOGY
Suzanne Mahady, Timothy Schlub, Lisa Bero, David Moher, David Tovey, Jacob George, Jonathan Craig
8.
TOPICAL STEROID THERAPY FOR THE TREATMENT OF EOSINOPHILIC OESOPHAGITIS (EOE) - A SYSTEMATIC REVIEW AND
META-ANALYSIS
Chuang Ming-yu, Mohamed Chinnaratha, Richard Woodman, Charles Cock, Robert Fraser
9.
OBSTACLES TO DONOR RECRUITMENT FOR FAECAL MICROBIOTA TRANSPLANTATION – EXPERIENCES FROM THE FOCUS
STUDY
Sudarshan Paramsothy, Thomas Borody, Enmoore Lin, Sarah Finalyson, Alissa Walsh, Douglas Samuel, Johan van den
Bogaerde, Mitchell Hazel, Nadeem Kaaokoush, Michael Kamm
30.
THE SIGNIFICANCE OF DUODENAL THICKENING ON COMPUTERISED TOMOGRAPHY(CT)
Zaid Ardalan, Gregory Moore
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
31.
AMONGST PATIENTS WITH CT DIAGNOSIS OF COLON THICKENING , HOW DOES THE CLINICAL PRESENTATION CORRELATE
WITH THE HISTOLOGIC DIAGNOSIS?
Zaid Ardalan, Sujievan Chandranm, Gregory Moore
47.
CLINICAL IMPLICATIONS OF DELAYED SURVEILLANCE COLONOSCOPY IN AN ABOVE AVERAGE RISK POPULATION: DATA
FROM A LARGE REGIONAL REGISTRY
Chuang Ming-yu, Erin Symonds, Charles Cock, Richard Woodman, Samhita Penukonda, Stephen Cole, Peter
Bampton,Robert Fraser
67.
ENDOSCOPIC INVESTIGATION IN IRON DEFICIENCY COMPARED WITH NON-IRON DEFICIENCY ANAEMIA
Tamara Mogilevski, Adam Testro, Patrick Charles, Rhys Vaughan, Leonid Cherilov, Douglas Johnson, Rebecca Smith
75.
SYMPTOMS AT PRESENTATION DO NOT DIFFERENTIATE PATIENTS WITH COELIAC DISEASE FROM IRRITABLE BOWEL
SYNDROME AND FUNCTIONAL DYSPEPSIA
James Hunt, Andrew Keegan, Marjorie Walker, Cheng Liu
89.
HELICOBACTER PYLORI DIAGNOSED DURING ENDOSCOPY: TREATMENT AND FOLLOW-UP
Dileep Mangira, Ming-Yu (Anthony) Chuang, Samantha Cole, Grace Seiboth, Stamatiki Kritas, Carly Burgstad, Charles
Cock
101.
FACTORS INFLUENCING FAECAL IMMUNOCHEMICAL TEST POSITIVITY RATE: DEMOGRAPHIC, PATHOLOGICAL, BEHAVIORAL
AND ENVIRONMENTAL EFFECTS
Erin Symonds, Joanne Osborne, Stephen Cole, Peter Bampton, Robert Fraser, Graeme Young
103.
A METHYLATED DNA BLOOD TEST FOR COLORECTAL CANCER SCREENING RETURNS A LOWER FALSE POSITIVITY RATE
THAN A FAECAL IMMUNOCHEMICAL TEST IN PEOPLE WITH BENIGN BLEEDING CONDITIONS
Erin Symonds, Susanne Pedersen, Joanne Osborne, Geetha Gopalsamy, Snigdha Gaur, David Murray, Aidan McEvoy,
Rohan Baker, Stephen Cole, Lawrence LaPointe, Graeme Young
119.
A RAPID CLINICAL RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY IN REFRACTORY CRONKHITE-CANADA
SYNDROME
Helen Myint, Neeraj Bhala, Nigel Stace
126.
ENDOSCOPIC AND HISTOLOGIC FINDINGS IN FOOD BOLUS OBSTRUCTION: NOT ALL EOSINOPHILIC OESOPHAGITIS
Alkesh Zala, Steven Bollipo, Marjorie Walker, Nicholas Talley
138.
COMPOUNDED LEVOFLOXACIN TRIPLE THERAPY FOR TREATMENT RESISTANT HELICOBACTER PYLORI
Vikas Gupta, Srey Neth Loch, David Van Der Poorten
163.
VALIDATION OF THE CURRENT LYNCH SYNDROME PREDICTIVE MODELS IN CHINESE POPULATIONS
Chun Gan, Mark Jenkins, Finlay Macrae
166.
SUCCESS AND TIMECOURSE OF REACHING THE THERAPEUTIC GOALS WITH A GLUTEN-FREE DIET IN COELIAC DISEASE: A
PROSPECTIVE FIVE-YEAR STUDY FROM DIAGNOSIS
Evan Newnham, Sue Shepherd, Patrick Hosking, Boyd Strauss, Peter Gibson
182.
SERVICE AND QUALITY IMPROVEMENT: �PATIENTS PREFER LOCAL HEALTHCARE’ - WAITING LIST REDUCTION INITIATIVES
CONFIRM THAT PATIENTS PREFER �LOCAL’ HEALTHCARE PROVISION – THE PRINCE CHARLES EXPERIENCE
Ann Vandeleur, Joanne Swain, Marelle Best, Sherran Gilani, Gillian Schofield, Belinda Kerwin, Natalie Andrea, Vanessa
Campbell, Patricia Fossey, Mark Appleyard, Ruth Hodgson, Tony Rahman
49
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
50
185.
SERVICE AND QUALITY IMPROVEMENT: PROFILING THE FAILURE TO ATTEND PATIENT (FTA), TARGETING RESOURCES AND
IMPROVING SERVICE PROVISION DESPITE INCREASED ACTIVITY - THE PRINCE CHARLES EXPERIENCE
Ben Law, Patricia Fossey, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, John Croese, Mark
Appleyard, Ruth Hodgson, Tony Rahman
232.
PROSPECTIVE SINGLE-BLINDED SINGLE-CENTRE RANDOMIZED CONTROLLED TRIAL IN COMPARING MOVIPREP, A
POLYETHYLENE GLYCOL-BASED SOLUTION WITH PREPKIT C, A COMBINED POLYETHYLENE GLYCOL AND SODIUM
PICOSULFATE-BASED SOLUTION IN THE PREPARATION OF PATIENTS FOR COLONO
Tady Kordian, Astrid-Jane Greenup, Jenn Hian Kenenth Koo, Wa Sang Ng, Susan Connor
244.
DIAGNOSTIC YIELD OF [99M TC] PERTECHNATATE SCINTIGRAPHY SCAN IN ADULTS WITH SUSPECTED MECKEL’S
DIVERTICULUM
Pruthviraj Uchila, Chiang Siah
249.
ESTABLISHMENT OF A FAECAL MICROBIOTA TRANSPLANT SERVICE FOR THE TREATMENT OF RECURRENT CLOSTRIDIUM
DIFFICILE COLITIS IN THE AUSTRALIAN PUBLIC HOSPITAL SETTING
Samuel Costello, Justin La Brooy, Emily Tucker, Richard Holloway, Mark Schoeman, Jane Andrews
252.
HIGH YIELD FOR ADVANCED COLORECTAL NEOPLASIA (CARCINOMA AND ADVANCED ADENOMA) DETECTION WITH
COMMUNITY BASED FAECAL IMMUNOCHEMICAL TESTING
Samarth Rao, Kannan Venugopal
255.
HALO RADIOFREQUENCY ABLATION FOR RESISTANT GASTRIC ANTRAL VASCULAR ECTASIA (GAVE)
Eng Gan, Chiang Siah
267.
DETECTION OF VARIABLE METHYLATION PATTERNS IMPROVES COLORECTAL CANCER BLOOD TEST SENSITIVITY
Rohan Baker, Snigdha Gaur, David Murray, Aidan McEvoy, Graeme Young, Lawrence LaPointe, Susanne Pedersen
279.
CHROMOGRANIN A – A USEFUL SCREENING TOOL FOR THE ELUSIVE NEUROENDOCRINE TUMOUR
Raphael Luber, Anil Asthana, Sasha Fehily, Peter Gibson
293.
SUBSEROSAL EOSINOPHILIC GASTROENTERITIS WITH ASCITES – CASE REPORT OF A RARE DISEASE
Wiyang Szetoo, John Ombiga, Peter Boyd, Rachelle Haikings
306.
HYDROGEN BREATH TESTS: ARE THEY OVERUTILISED?
Hamish Philpott, Emily Nixon, Jarrod Greenhalgh, Sanjay Nandurkar
308.
DEVELOPMENT OF NOVEL T-CELL BASED ASSAYS TO IMPROVE THE DETECTION OF COELIAC DISEASE
Michael Xiang Ma, Geoffrey Millar Forbes, Jessica Jorritsma, Niamh Keane, Mina John
322.
A POTENTIAL CHEMOPREVENTATIVE FOOD FOR FAMILIAL ADENOMATOUS POLYPOSIS: THE AUSFAP STUDY
Julie Clarke, Finlay Macrae, Alex Boussioutas, Trevor Lockett
323.
CHARACTERISTICS AND OUTCOMES OF OCTOGENARIANS AND NONAGENARIANS DIAGNOSED WITH COLORECTAL CANCER
AT A TERTIARY HOSPITAL
Claire Gordon, Oyekoya Ayonrinde, Thomas Hendricks, Charitha Ranaweera, Marina Wallace
339.
GENETIC VARIATION IN PNPLA3 (RS738409) AND RISK OF ESOPHAGEAL ADENOCARCINOMA
Alex Choo, A P Thrift, D C Whiteman, P J Clark
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
MOTILITY/NEUROGASTROENTEROLOGY
40.
INTESTINAL MUCOSITIS INDUCED BY 5-FLUOROURACIL RESULTS IN SPINAL ASTROCYTE EXPRESSION CHANGES IN RATS
Juliana Bajic, Gordon Howarth, Georgina Eden, Lorrinne Lampton, Suzanne Mashtoub, Mark Hutchinson
170.
REFRACTORY GASTROPARESIS CAN BE SUCCESSFULLY MANAGED WITH ENDOSCOPIC TRANSPYLORIC STENT PLACEMENT
AND FIXATION
Payal Saxena, Vivek Kumbhari, Ahmed Mesallam, Mohamad El Zein, Ahmed Abdelgelil, John Clarke, Anthony Kalloo,
Mouen Khashab
195.
PERORAL ENDOSCOPIC MYOTOMY (POEM) IS COST EFFECTIVE WHEN COMPARED TO LAPAROSCOPIC HELLER MYOTOMY
(LHM) FOR THE TREATMENT OF ACHALASIA
Vivek Kumbhari, Payal Saxena, Mohamad El Zein, Manvi Solanki, John Clarke, Anthony Kalloo, Mouen Khashab
196.
PNEUMATIC DILATATION (PD) VS. LAPAROSCOPIC HELLER MYOTOMY (LHM) VS. PERORAL ENDOSCOPIC MYOTOMY (POEM)
FOR THE TREATMENT OF ACHALASIA: A SINGLE CENTRE EXPERIENCE
Vivek Kumbhari, Payal Saxena, Mohamad El Zein, John Clarke, Anthony Kalloo, Mouen Khashab
220.
HIGH RESOLUTION MANOMETRIC CORRELATES OF OESOPHAGEAL BOLUS CLEARANCE IN AGEING USING AIM PRESSURE
FLOW ANALYSIS
Charles Cock, Stamatiki Kritas, Carly Burgstad, Alison Thompson, Laura Besanko, Richard Heddle, Robert Fraser, Taher
Omari
275.
CAN GASTROENTEROLOGISTS PERFORM POEM SAFELY AND EFFECTIVELY IN THE ENDOSCOPY SUITE WITHOUT A
SURGEON?
Vivek Kumbhari, Payal Saxena, Mohamad El Zein, Ahmed Abdelgelil, John Clarke, Anthony Kalloo, Mouen Khashab
276.
UNDERSTANDING THE MECHANISMS UNDERLYING CHRONIC PAIN IN IBD: A NEW METHOD FOR STUDYING VISCERAL INPUTS
FROM THE GASTROINTESTINAL TRACT
Kristen Farrell, Brett Graham, Simon Keely, Robert Callister
300.
UPDATE ON THE USE OF TRANSCUTANEOUS ELECTRICAL STIMULATION TO OVERCOME FUNCTIONAL MOTILITY DISORDERS
Bridget Southwell, Tony Catto-smith, John M Hutson
320.
PREDICTORS OF RECURRENT EMERGENCY DEPARTMENT PRESENTATION IN ADULTS WITH CONSTIPATION
Adrian Cakra, Samapriya Hewawasam, Angela Khera, Rebecca Burgell
321.
CAN
Vivek Kumbhari, Payal Saxena, Alan Tieu, Manabu Onimaru, Mohamad El Zein, Rani Modayil, Ezra Teitelbaum, Ahmed
Messallam, Matthew Gitelis, Stavros Stavropoulos, Eric Hughness, Michael Ujiki, Hironari Shiwaku, Philip Chiu, Haruhiro
Inoue, Moen Khashab
NUTRITION
42.
ARE CHILDREN ON JEJUNAL FEEDS AT RISK OF IRON DEFICIENCY?
Li Zsa Tan, Susan Adams, Alison Kennedy, Felicity Fletcher, Chee Y Ooi
62.
FEASIBILITY AND SAFETY OF USING OVERTUBES FOR PEG-TUBE PLACEMENT IN PATIENTS WITH HEAD AND NECK CANCER:
A SINGLE-CENTER STUDY
Crispin Musumba, Julia Hsu, Golo Ahlenstiel, Nicholas Tutticci, Kavinderjit Nanda, David van der Poorten, Eric Lee, Vu
Kwan
51
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
70.
INTENSIVE MEDICAL WEIGHT LOSS PROGRAMME ACHIEVES SIGNIFICANT RAPID PRE-OPERATIVE WEIGHT LOSS IN THE
OBESE POPULATION
Benedict Devereaux, Christine Skinner, Rachel Myhill, George Hopkins
106.
EVALUATION OF SERUM FERRITIN AS A MARKER OF IRON STATUS IN YOUNG AUSTRALIAN ADULTS
Elizabeth McKinnon, Anita Chua, Wendy Oddy, Leon Adams, Oyekoya Ayonrinde, John Olynyk
112.
HIGH IRON AND TRANSFERRIN SATURATION LEVELS ARE ASSOCIATED WITH INCREASED RISKS OF NON-SKIN CANCERS IN
WOMEN
Anita Chua, Mark Divitini, Debbie Trinder, Matthew Knuiman, John Olynyk
245.
ECONOMIC COSTS OF PARENTERAL NUTRITION WITH A NUTRITIONAL SUPPORT TEAM
Jateen Mistry, Andrew Lee, Sally Porter, Michelle Palmer, Susan Ko, Marjoree Sehu, Jeremy Rajanayagam
318.
DIETARY RESISTANT STARCH IMPROVES BONE ZINC CONTENT IN RATS REGARDLESS OF ZINC STATUS
Geetha Gopalsamy, Graeme Young, Cuong Tran, Elissa Mortimer, Ying Hu
PAEDIATRICS
52
12.
CAN COELIAC DISEASE BE DIAGNOSED SOLELY BASED ON SEROLOGY?
Cheng Hiang Lee, Anja Klasen, Andrew Williams, Kevin Gaskin
32.
GASTRO-DUODENAL FISTULA CAUSED BY MULTIPLE MAGNET INGESTION: A CASE REPORT OF SUCCESSFUL ENDOSCOPIC
MANAGEMENT IN A CHILD
Ajay Sharma, Peggy Marcon, Govind Chavhan, Shyam Mohan, Priscilla Chiu, Pavan Brahmamdan
74.
STEROID-FREE REMISSION IN ADALIMUMAB-TREATED PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE
CROHN’S DISEASE IN THE IMAGINE 1 TRIAL
Nicolas Martin, Wallace Crandall, Anne Griffiths, Richard Colletti, Frank Ruemmele, William Faubion, Jeffrey Hyams,
Andreas Lazar, Yao Li, Samantha Eichner, Roopal Thakkar
118.
AN EFFORT TO REDUCE UNNECESSARY COLONOSCOPY IN PAEDIATRIC PATIENTS - A 10 YEAR RETROSPECTIVE AUDIT
Patricia Kawada, Edward Vincent O’Loughlin, Michael Oswald Stormon, Shoma Dutt, Annabel Magoffin, Cheng Hiang Lee,
Kevin John Gaskin
160.
METASTATIC CROHN’S DISEASE IN CHILDREN – SINGLE CENTRE EXPERIENCE
Kunal Thacker, Nil Ranwala, Zubin Grover, David Forbes, Catherine Mews, Madhur Ravikumara
194.
LONG TERM OUTCOME OF NEONATAL HEMOCHROMATOSIS: A REVIEW OF TWO DECADES OF EXPERIENCE
Su Saint Lee, Cheng Hiang Lee, Patricia Kawada, Edward O’Loughlin, Annabel Magoffin, Kevin Gaskin, Michael Stormon
240.
ROLE OF ASCA AND ANCA IN PREDICTING THE SEVERITY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE
Shivani Kansal, Josef Wagner, Sarah Thomas, Don Cameron, Mark Oliver, George Alex, Winita Hardikar, Vered
Schildkraut, Carl Kirkwood, Anthony Graeme Catto Smith
257.
IMPACT OF CAMPYLOBACTER CONCISUS ON PAEDIATRIC INFLAMMATORY BOWEL DISEASE
Steven Leach, Lucy Mcmullen, Si Ming Mann, Nadeem Kaakoush, Hazel Mitchell, Daniel Lemberg, Andrew Day
264.
TACROLIMUS USE IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE
Steven Leach, Rebecca Foster, Daniel Lemberg, Andrew Day
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
307.
HOW EFFECTIVE IS COMBINED POLYETHYLENE GLYCOL AND SODIUM PICOSULPHATE FOR DISIMPACTION IN CHILDREN WITH
CHRONIC CONSTIPATION AND PALPABLE FAECALOMA?
Bridget Southwell, Lauren Dughetti, Julie Jordan-Ely, Lefteris Stathopoulos, Marcello Leal, Tony Catto-Smith, John M
Hutson
311.
EVALUATION OF THERAPEUTIC �PLAY PICNICS’ TO MINIMISE THE UNWANTED SIDE EFFECT OF TUBE DEPENDENCY IN
ENTERALLY FED CHILDREN
Alison Forrest, Lynly Mader, Kate King, Jodi Grunert, Meg Prior
336.
COLLAGENOUS GASTRITIS - SERIES OF FOUR PAEDIATRIC CASES FROM A SINGLE INSTITUTION
Catherine Mews, Clugston Stephanie, Madhur Ravikumara, David Forbes, Gareth Jevon
VIRAL HEPATITIS
52.
HAZARDOUS ALCOHOL USE IS MORE STRONGLY ASSOCIATED WITH CIRRHOSIS COMPLICATIONS THAN OBESITY AND
DIABETES IN PATIENTS WITH CHRONIC HEPATITIS C: PRELIMINARY RESULTS OF A CASE-CONTROL STUDY
Guang Chen, Shivakumar Chitturi, Graham Kaye, Narci Teoh, Geoff Farrell
78.
QUAC: Q80K MUTATION PREVALENCE IN AN AUSTRALIAN HEPATITIS C POPULATION
Adrian Teck Leng Ong, Jacob George, Mark W Douglas
80.
REAL-WORLD EXPERIENCE OF TENOFOVIR AND ENTECAVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B IN A LARGE
METROPOLITAN HEALTH SERVICE IN VICTORIA
Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel
81.
IDENTIFYING CHRONIC HEPATITIS B PATIENTS WHO MAY BE SUITABLE FOR MONITORING IN THE COMMUNITY: PREDICTORS
OF STABILITY IN IMMUNE-CONTROL PHASE
Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel
91.
SAFETY COMPARISON OF 12- AND 24-WEEK TREATMENTS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS:
RESULTS FROM TURQUOISE-II
Jonathan Anderson, Heiner Wedemeyer, Xavier Forns, Antonio Craxi, Nancy Reau, Paul Kwo, Stefan Bourgeois, Michael
Bennett, Stephen Ryder, Dominique Larrey, David Mutimer, Sandra Lovell, Manal Abunimeh, Marcos Pedrosa, Roger
Trinh
96.
SVR12 OF 99% ACHIEVED WITH A RIBAVIRIN-FREE REGIMEN ABT-450/R/OMBITASVIR AND DASABUVIR IN HCV GENOTYPE
1B –INFECTED PATIENTS
Martin Weltman, Andreas Maieron, Massimo Puoti, Jeffrey V Enejosa, Pietro Andreone, Ziv Ben Ari, Gunnar Norkrans,
Manuel Romero-Gomez, Wangang Xie, Daniel E Cohen, Thomas Podsadecki
97.
VIRAL AND NON-VIRAL FACTORS AFFECTING HEALTH-RELATED QUALITY OF LIFE IN CHRONIC HEPATITIS C
Kendall Williams, Adele Hampson, Thomas Lee, Ria Kanazaki, Omar Sharaiha, Heidi Cheung, Micaela Lucas
99.
ADVERSE EVENT PROFILE OF THE INTERFERON-FREE ALL-ORAL ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN
REGIMEN IN HCV PATIENTS
Jacob George, Donald Jensen, Tolga Baykal, Eric Lawitz, Jordan Feld, Gioacchino Angarano, Saumya Jayakumar, Tania
Welzel, Eoin Coakley, Julia Xiong, Barbara Da Silva-Tillmann, Lois Larsen
53
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
54
120.
PATIENTS LOST TO FOLLOW UP: THE EXPERIENCE OF AN AUSTRALIAN HEPATITIS B CLINIC
Phil Ha, Vanessa Bull, Natassia Tan, Stephanie Spring, Lukas Sahhar, Suong Le, Anouk Dev
142.
SUCCESSFUL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 WITH TRIPLE THERAPY USING DIRECT
ANTIVIRAL AGENTS, IN RURAL AND REMOTE REGIONAL WESTERN AUSTRALIA (WA)
Chandrin Jayasundera, Lydia Scott, Stephen Hinton, Camilla Hey, Lesley Norman, Charles Greenfield, Saroj Nazareth,
Mya Yee, John Lindsey, Jaye Martin, Wendy Cheng
150.
FACTORS ASSOCIATED WITH COMPLIANCE AND ADHERENCE IN THE TREATMENT OF CHRONIC HEPATITIS C INFECTION AT A
TERTIARY CENTRE
Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Wendy Cheng
152.
LONG-TERM “REAL WORLD” EXPERIENCE WITH TENOFOVIR AND ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B:
A WESTERN AUSTRALIAN TERTIARY CENTRE EXPERIENCE
Sherman Picardo, Zi Ng, Samarth Rao, James Flexman, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Wendy Cheng
159.
HEALTH AND ECONOMICAL IMPACT OF OCCUPATIONAL INJURIES FROM HEPATITIS C POSITIVE SOURCES OVER TWO
DECADES IN A TERTIARY HOSPITAL SETTING
Astrid-Jane Greenup
178.
THE GOOD RESPONSE IL28B GENOTYPE IS ASSOCIATED WITH HIGH GRADE LIVER NECROINFLAMMATION AND INCREASED
EXPRESSION OF THE CHEMOKINE CXCL9 IN LIVER AND PLASMA
Jacinta Holmes, Narelle Skinner, Mario Congiu, Rosemary Millen, Sally Bell, Tin Nguyen, David Iser, Scott Bowden,
William Sievert, Paul Desmond, Kumar Visvanathan, Alexander Thompson
189.
ELDERLY AGE IS NOT ASSOCIATED WITH REDUCED SUSTAINED VIROLOGICAL RESPONSE IN THE TREATMENT OF GENOTYPE
1 CHRONIC HEPATITIS C INFECTION
Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Rhoda Tuma, Wendy Cheng
190.
MAPPING THE HBSAG IMMUNE PHENOTYPE TO PREDICT HBSAG DECLINE IN CHRONIC HEPATITIS B IN PATIENTS RECEIVING
NUCLEOT(S)IDE ANALOGUE THERAPY
Lucy Lim, Lilly Yuen, Rachel Hammond, Peter Angus, Alexander Thompson, Scott Patterson, Tom Leary, Peng Yi, Howard
Thomas, Stephen Locarnini, Renae Walsh
201.
THE CHANGING PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION TREATED AT A TERTIARY CENTRE IN
WESTERN AUSTRALIA OVER THE LAST DECADE
Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Rhoda Tuma, Marion McInerney, Terri
Budge, Sook-Ling Chen, Nadine Leembruggen, Nigel Armstrong, Alexandra Welborn, James Flexman, Wendy Cheng
204.
DEFICIENCIES IN THE CURRENT CLASSIFICATION OF CHRONIC HEPATITIS B PHASES: EXPERIENCES FROM REAL-WORLD
PRACTICE
Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel
263.
THE EFFECTS OF TENOFOVIR AND ENTECAVIR ON RENAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS B TREATED FOR
TWO YEARS AT A TERTIARY CENTRE
Zi Yun Ng, Jee Yuen Kong, Nick Kontorinis, Lorenzo Tarquinio, Sam Rao, Sherman Picardo, James Flexman, Wendy Cheng
265.
ABSTRACT: METALLOTHIONEINS MODULATE HCV REPLICATION AND IFNL3 MEDIATED ANTIVIRAL RESPONSE
Scott Read, Kate O’Connor, Mark Douglas, David Booth, Jacob George, Golo Ahlenstiel
Australian Gastroenterology Week 2014
Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014
285.
THE CORRELATION BETWEEN HEPASCORE AND FIBROSCANВ® IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
Sherman Picardo, Jee Kong, Nick Kontorinis, Lorenzo Tarquinio, Leon Adams, Saroj Nazareth, Nadine Leembruggen,
Terri Budge, Sook Ling Chen, Wendy Cheng
313.
AN ENTECAVIR (ETV) AND TENOFOVIR (TDF) REAL WORLD STUDY – A RETROSPECTIVE REVIEW OF LONG TERM ENTECAVIR
AND TENOFOVIR THERAPY IN CHRONIC HEPATITIS B IN AUSTRALIA
Rebekah Van Leest
55
Document
Category
Health and Medicine
Views
1 233
File Size
250 KB
Tags
1/--pages
Report inappropriate content